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A adenine
ACG1B achondrogenesis 1B
AE anion exchanger
Alu repetitive sequence in human genome
AO2 atelosteogenesis 2
APUD amine precursor uptake decarboxylase
BAC bacterial artificial chromosome
bp base pair
C cytosine
CCM chemical cleavage mismatch
CD Crohn’s disease
cDNA complementary deoxyribonucleic acid
CF cystic fibrosis
CFTR cystic fibrosis transmembrane conductance regulator
Cl- chloride anion
CLD congenital chloride diarrhea
CpG island a short stretch of DNA containing unmethylated CpG dinucleotides
CU ulcerative colitis
DAB diaminobenzidine
DGGE denaturing gradient gel electrophoresis
DIDS 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid
DLD dihydrolipoamide dehydrogenase
DNA deoxyribonucleic acid
DTD diastrophic dysplasia
DTDST diastrophic dysplasia sulfate transporter
ECM enzymatic cleavage mismatch
EST expressed sequence tag
G guanine
HCO3- bicarbonate anion
HGNC Human Gene Nomenclature Committee
HUGO Human Genome Organization
IBD inflammatory bowel disease
kb kilobase pairs (1 kb= 1000 bp)
KCl potassium chloride (salt)
kDa kilodalton
LAMB1 laminin beta1
MED multiple epiphyseal dysplasia
MIM Mendelian Inheritance in Man
mRNA messenger RNA
Na+ sodium cation
NaCl sodium chloride (salt)
NHE Na+/H+ exchanger
nt nucleotide
OH- hydroxide anion
p short arm of a chromosome
PAGE polyacrylamide gel electrophoresis
PCR polymerase chain reaction
9PDS Pendred syndrome
PRKAR2B beta2 subunit of a cAMP-dependent protein kinase
PTT protein truncation test
q long arm of a chromosome
RNA ribonucleic acid
RT-PCR reverse transcriptase polymerase chain reaction
SAT-1 human sulfate anion transporter 1
Sat-1 rat sulfate anion transporter 1
SCFA short chain fatty acid
SDS sodium dodecyl sulfate
SLC solute carrier
SO42- sulfate anion
SSCP single-stranded conformational polymorphism
T thymidine
TGGE temperature gradient gel electrophoresis
UPD uniparental disomy
V317del deletion of a valine at codon 317
YAC yeast artificial chromosome
TABLE OF GENE NOMENCLATURE IN THIS THESIS
Approved name Aliases Functional/disease name
by nomenclature
committee
SLC26A1 SAT-1 sulfate anion transporter-1
SLC26A2 DTDST diastrophic dysplasia sulfate transporter
SLC26A3 CLD, congenital chloride diarrhea
DRA down-regulated in adenoma
SLC26A4 PDS the Pendred syndrome gene
Slc26a5 prestin
SLC26A6
SLC4A1 AE1 anion exchanger 1
SLC4A2 AE2 anion exchanger 2
SLC4A3 AE3 anion exchanger 3
SLC9A1 NHE1 sodium-hydrogen exchanger 1
SLC9A2 NHE2 sodium-hydrogen exchanger 2
SLC9A3 NHE3 sodium-hydrogen exchanger 3
Human gene symbols are in capital letters (for example DRA) while for the rodent genes
the symbols are in lowercase letters (for example dra). See p. 25 for the detailed discussion
and references of the nomenclature.
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SUMMARY
Congenital chloride diarrhea (CLD) is a rare autosomal recessive intestinal disorder with
worldwide distribution. It is particularly prevalent in Finland due to a genetic founder
effect and thus belongs to the Finnish disease heritage. Other high-frequency areas include
Poland, and the Arabic countries Saudi-Arabia and Kuwait. The basic defect in CLD
involves the ileal and colonic Cl-/HCO3- exchange leading to watery diarrhea with a high
concentration of chloride.
At the beginning of this study, refined mapping had provided two positional and
functional candidate genes: PRKAR2B and DRA. Direct sequencing of Finnish and Polish
CLD patient samples revealed three different mutations, which confirmed the identity of
the DRA gene as the CLD gene. The Finnish major mutation was shown to be a three base
pair deletion V317del that was present in all CLD chromosomes studied. Another
missense mutation H124L was found in heterozygous form in two unrelated Polish
patients who shared an identical haplotype in one chromosome. Finally, finding a
frameshift causing deletion 344delT further supported the role of DRA as the CLD gene
(I).
The genomic structure of the human CLD gene was determined by direct sequencing of
genomic DNA clones and genomic PCR products. Large-scale sequencing of a BAC clone
containing the CLD gene was also employed. The human CLD gene spans about 30 kb of
genomic DNA and consists of a total of 21 exons separated by 20 introns. In addition, the
600 bp of the 5’ flanking region was analyzed by computer to reveal a putative
transcription start site and transcription factor binding sites. This enabled the design of
primer pairs to amplify each exon separately in the same conditions, which facilitated the
screening of yet unidentified mutations and thus provided a system for the molecular
diagnosis of CLD. (II)
So far, 28 different mutations in CLD patients from several ethnic backgrounds have been
identified. Three of them represent founder mutations responsible for the clustering of the
disorder in the high-frequency areas. A high proportion of mutations seem to concentrate
into three segments, suggesting either mutational hot-spots or the functional importance of
these parts of the CLD protein. (I, III, unpublished data)
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In situ hybridization study using an antisense cRNA probe revealed mRNA expression of
the human CLD gene in surface epithelial cells of the upper one-third of the colonic crypt.
The CLD protein colocalized with mRNA. In addition to colon, CLD is expressed in
seminal vesicle and sweat gland, which are not known to be affected in congenital chloride
diarrhea. No significant change in CLD expression could be detected in colon samples
with inflammation. Search for CLD expression in the multiple malignant colonic tissues
revealed an expression that was down-regulated at a later stage than previously thought (I,
IV).
In rat tissues, the northern analysis of the highly homologous transporter, the dtdst gene,
had shown expression in the intestine and calvaria, which triggered us to study the in vivo
expression of the DTDST gene in the colon and in various other human tissues.
Immunohistochemistry revealed colonic DTDST expression that colocalizes partially with
that of CLD. Expression was also observed in developing and mature cartilage
corresponding to the phenotype caused by mutant alleles. In addition, some other tissues
with no functional defect in DTD showed expression. Although DTDST is expressed in
the colon, it is, however, obvious that it is not able to compensate for the dysfunction of
the defective CLD protein as demonstrated by the phenotype of CLD patients (IV, V).
In these studies we have resolved the genetic background of CLD, which has enabled us to
develop a system for extensive mutation screening. This will yield an immediate
improvement for diagnosis and genetic counseling. Understanding the molecular
pathology behind the CLD phenotype is also important for designing a specific and more
effective treatment for CLD patients.
Finally, identifying the gene responsible for congenital chloride diarrhea also revealed the
identity of a major human ileal and colonic apical Cl-/HCO3- (or Cl-/OH-) exchanger. Our
studies provide a starting point for the functional analysis of the normal CLD protein,
which will lead to detailed knowledge of the basic electrolyte transport physiology of the
human colon and important processes involved in the maintenance of electrolyte and pH
homeostasis of man.
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1. REVIEW OF THE LITERATURE
1.1. Structure and histology of the intestine
The intestinal tract is a long tubular structure starting from the stomach and ending to the
rectum. It consists of two functionally and structurally related parts: the small and large
intestine. The small intestine can be further divided into duodenum, jejunum, and ileum
and the large intestine, or the colon, into cecum, ascending, transverse, descending, and
sigmoid colon. The intestine serves a number of functions, the main function being the
absorption of nutrients, water, and electrolytes. The intestinal wall consists of four layers:
the mucosa, submucosa, external muscular layer, and serosa. In the small intestine, the
mucosa and submucosa are modified to increase the luminal surface area by intestinal
folds, villi, and microvilli, while the colon is less amplified due to absence of villi.
(Guyton, 1991; Ross and Romrell 1989; Dharmsathaphorn, 1994)
The mucosa is comprised of an epithelium, a lamina propria, and a muscularis mucosae.
The muscularis mucosae is a smooth muscle layer (inner circular and outer longitudinal)
that constitutes the deepest part of the mucosa at the mucosal-submucosal boundary. The
lamina propria is a connective tissue layer, which in addition to usual connective tissue
cells, contains numerous defense system cells like lymphocytes, plasma cells, and
eosinophils, which respond to microbes and other foreign substances. In addition, nodules
of lymphatic tissue are found throughout the intestinal mucosa usually extending into the
submucosa. Numerous simple tubular glands extend through the full thickness of the
mucosa and open into the intestinal lumen. (Ross and Romrell, 1989)
The intestinal epithelium consists mainly of five different cell types: enterocytes, goblet
cells, APUD (amine precursor uptake decarboxylase) cells, Paneth cells, and
undifferentiated cells. In addition, lymphocytes are usually present within the epithelium.
Mucus producing goblet cells are more abundant in colon than in small intestine and are
mainly located in intestinal crypts and villi. Mucus serves as a lubricate allowing easy
passage of increasingly solid colonic content. It also serves as a protective barrier against
some intestinal contents such as bacteria and digestive enzymes. Some APUD and
undifferentiated cells are also present in the epithelial crypts. However, the major cell type
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is the enterocyte, which is a columnar cell lining the intestinal surface but is also found in
glands. The enterocytes function as absorptive epithelial cells primarily responsible for the
absorption of nutrients, electrolytes, and water in the small intestine, while in the colon
they are mainly engaged in the restoration of electrolytes and water. Intestinal epithelial
cells arise from progenitor cells in the base of the crypt and migrate along the crypt to
become mature surface epithelial cells which are subsequently after a 3- to 6-day period
shedded into intestinal lumen. Although epithelial cells are derived from the same origin, a
clear functional separation between the crypt and surface epithelial cells exists. (Guyton,
1991; Ross and Romrell, 1989; Dharmsathaphorn, 1994)
One or multiple layers of epithelial cells line both the external surfaces and internal
cavities of the body. In addition, epithelium covers the secretory portion of glands and
their ducts, and it also forms some receptor cells of certain sensory organs. Any substance
that is absorbed into the body or discharged from it has to pass through epithelial cells.
The structure of the epithelium is determined by its function. In the skin, where the
epithelium serves as an almost impermeable barrier, it consists of multiple cell layers,
while in the intestine where epithelium is involved in absorption and secretion, it consists
of only one layer of columnar cells. (Ross and Romrell, 1989)
A lipid bilayer in the epithelial cell wall constitutes a barrier for the movement of water
and water-soluble substances between extra- and intracellular spaces. However, some
substances can penetrate the lipid bilayer by themselves in order to enter the cell or to
leave it. Large amounts of proteins are floating in the lipid bilayer thus interrupting its
continuity. Many of these proteins are transport proteins, which can be divided into
channel proteins and carrier proteins. Channel proteins have a watery space through them
and allow the movement of certain ions or molecules, while carrier proteins bind with
substances to be transported, conformational changes in the carrier moving the substances
through to the other side of the membrane. (Guyton, 1991; Berne et al., 1994)
1.2. Role of Cl-/HCO3- exchange in ileum and colon
The intestinal fluid absorption and secretion are secondary to the movements of
electrolytes, mainly sodium and chloride, through the cell membranes. The permeability of
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the intestine decreases in the distal direction and in the colon the epithelium is poorly
permeable, which makes an active transport system highly necessary. The absorptive
processes primarily take place in the surface/villous epithelium where the substances to be
absorbed are in close contact to the large surface area, while secretory processes are
localized more to the crypt epithelial cells (Welsh et al., 1982). However, also the surface
epithelium is involved in secretion to some extent (Stewart and Turnberg, 1989;
Kockerling and Fromm, 1993) and some absorption takes place in the colonic crypts
(Singh et al., 1995). Most studies on the electroneutral NaCl absorption have been
performed on rabbit ileum and rat colon. Although there are large regional (Sandle et al.,
1986) and species-specific differences between various systems responsible for active
transport, it is believed that the same key components exist in all species. Nevertheless,
their relative contribution to overall NaCl absorption is likely to vary.
1.2.1. Coupled NaCl absorption
Multiple mechanisms are involved in NaCl absorption in the intestinal epithelium. The
main component is the active Na+-K+-ATPase that establishes an electrochemical gradient
across the intestinal mucosa by the outward movement of three Na+ ions simultaneously
with the inward movement of two K+ ions at the basolateral membrane of the epithelial
cell (Charney and Donowitz, 1978; Kirk et al., 1980). This electrochemical gradient
provides the driving force for sodium translocation across the brush border membrane of
the epithelial cell via the Na+ channel or the Na+-dependent cotransporters and the
exchange carriers (Will et al., 1980; Hediger et al., 1987; Orlowski and Grinstein, 1997).
Intestinal chloride is absorbed either via a passive route along gradient generated by
electrogenic Na+ absorption or via an active electronegative transport system against the
gradient (Davis et al., 1983).
In the human ileum and colon the active transport system appears to be responsible for the
majority of NaCl absorption. Abundant research data indicate that coupled electroneutral
NaCl absorption occurs via a Na+/H+ exchange linked to a Cl-/HCO3- exchange at the
apical brush border membrane of the intestinal epithelial cell (Turnberg, 1970;
Knickelbein et al., 1985, 1988). While Na+ and Cl- are absorbed there is also a
simultaneous flux of H+ and HCO3- across the membrane, which is dependent on Na+ and
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Cl- but independent of one another. In addition, Cl- regulates the directionality of Cl-
/HCO3- exchange. Thus HCO3- can be either secreted or absorbed via Cl-/HCO3- exchange
but the direction does not influence Na+/H+ exchange activity (Feldman and Stephenson,
1990). The coupling of parallel ion exchanges is thought to occur through changes in
intracellular pH. Also various substances have been shown to regulate electronegative
NaCl absorption (Sundaram et al., 1991a; Sundaram, 1995). The transport proteins
carrying out the Na+/H+ exchange function are members of the mammalian Na+/H+
exchanger (alias SLC9) gene family with at least six well characterized isoforms
(Orlowski and Grinstein, 1997; Counillon and Pouyssegur, 2000). In many tissues, the Cl-
/HCO3- exchange activity has so far mainly been linked to three known anion transport
proteins of the AE (from anion exchanger; alias SLC4) gene family, namely AE1, AE2,
and AE3 (Alper, 1991).
Intestinal expression has been reported for all three members of the AE gene family (Alper
et al., 1999; Rajendran et al., 2000). The AE2 protein has been confirmed to localize at the
basolateral membrane of surface epithelial cells (Alper et al., 1999), suggesting it to be
responsible for Cl-/HCO3- activity there. However, at least two most likely distinct and
separate processes performing the Cl-/HCO3- and/or Cl-/OH- exchanges are present at the
apical membrane of epithelial cells in rat distal colon (Vaandrager and De Jonge, 1988;
Rajendran and Binder, 1993). Of these, Cl-/HCO3- transport was observed in surface but
not in cryptal epithelial cells, while Cl-/OH- exchange was demonstrated both in surface
and crypt epithelial cells (Rajendran and Binder, 1999). Cl-/HCO3- exchange is
substantially inhibited by Na+ depletion, which suggests Cl-/HCO3- exchange to be mainly
responsible for Na+ coupled chloride absorption in rat distal colon. Thus, the Cl-/OH-
exchanger present both in surface and cryptal epithelial cells is suggested to have a role
mainly in cell volume and/or pH homeostasis (Rajendran and Binder, 1999). However, the
relative contribution of these mechanisms to overall chloride absorption is likely to vary
regionally and between species.
Apical Cl-/HCO3- transporter is not solely responsible for ileal and colonic HCO3-
secretion but other mechanisms participate (Sheerin and Field, 1975; Geibel et al., 2000).
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Studies have failed to show the presence of the apical Cl-/HCO3- exchanger in lower
cryptal epithelial cells that also secrete HCO3-. In addition, only partial inhibition of anion
inhibitor DIDS for HCO3- transport could be established, which suggests a role for the Cl-
/OH- exchanger for DIDS effect (Geibel et al., 2000). Furthermore, there is a close
association between Cl- and HCO3- secretion. The cryptal chloride secretor cystic fibrosis
transmembrane conductance regulator (CFTR) has been shown to regulate different
transporters and to be linked to Cl- independent HCO3- secretion in human pancreatic duct
cell line, CFPAC-1 (Shumaker et al., 1999). In proximal duodenum of CFTR knockout
mice HCO3- secretion has been noted to be absent. HCO3- secretion probably occurs
through different mechanisms in colonic surface and cryptal epithelia (Geibel et al., 2000).
In a villus epithelial cell, Na+/H+ exchange activity is present in both apical and basolateral
membranes but in a crypt epithelial cell Na+/H+ exchange is restricted only to the
basolateral membrane (Knickelbein et al., 1988). So far, three of the Na+/H+ exchanger
isoforms have been localized to ileal and colonic epithelium. NHE1 is ubiquitously
expressed and localized to the basolateral membrane of rabbit ileal epithelial villus and
crypt cells (Yun et al., 1995). It is believed to perform housekeeping functions and
participate in intracellular pH (pHi) and cell volume regulation. Two Na+/H+ exchangers,
NHE2 and NHE3, are identified to be apical brush border membrane exchangers in
intestinal surface or villous epithelial cells (Hoogerwerf et al., 1996; Bookstein et al.,
1997). NHE3 has been proposed to be involved in Na+ absorption due to the simultaneous
stimulation of NaCl and water absorption and induction of NHE3 mRNA expression
caused by glucocorticoids (Yun et al., 1993). In addition, on the basis of diarrheal
phenotype occurring in mice lacking the functional Nhe3 gene (Schultheis et al., 1998b)
but not in mice lacking Nhe2 (Schultheis et al., 1998a), Nhe3 is most likely mainly
responsible for colonic Na+/H+ exchange concerning coupled NaCl absorption. However,
the roles of these two apical Na+/H+ exchangers most likely vary among species (Maher et
al., 1996; Donowitz et al., 1998; Wormmeester et al., 1998).
1.2.2. Cell volume regulation
Although most mammalian cells are located in an environment with almost constant
osmolarity, especially cells in the transporting epithelia, such as intestinal epithelia, are
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subject to rapid changes in cell volume. Alterations in cell volume are important events
during apoptosis and differentiation, as well as during hypertrophy and atrophy.
Mammalian cells utilize a wide variety of volume regulatory mechanisms, including ion
transport, osmolyte accumulation, metabolism, and changes in the transcription and
expression of genes. In addition, different mechanisms are responsible for determining
steady-state volume than for correcting acute changes. The fastest and most efficient
mechanism in responding to alterations in cell volume is the activation of ion transport
across the cell membrane, which occurs within minutes and is thus most likely achieved
by the redistribution of the existing transporters, not by protein synthesis (Janecki et al.,
1998).
The major ion transport systems activated following cell shrinkage are the basolateral Na+-
K+-2Cl- cotransporter (Geck and Pfeiffer, 1985) and the Na+/H+ exchangers (Orlowski and
Grinstein 1997). Activation of Na+/H+ exchange leads to intracellular alkalinization and a
parallel activation of coupled Cl-/HCO3- exchange (Ericson and Spring, 1982). The net
result is intracellular accumulation of K+, Na+, and Cl-, and thus cell swelling. In addition,
Na+-K+-ATPase is activated to replace accumulated Na+ by K+. However, not much is
known about the ion transport proteins participating in regulatory volume increase (RVI).
Activities of Na+/H+ exchangers NHE1 and NHE2 are upregulated by cell shrinkage,
while NHE3 is inhibited (Demaurex and Grinstein, 1994; Kapus et al., 1994). Of known
anion exchangers (AEs) AE2, but not AE1, is suggested to have a role in RVI (Jiang et al.,
1997). In cell swelling, mainly separate K+ and nonselective anion channels are activated,
but also electroneutral KCl cotransport. In some cells KCl exit is performed by a parallel
activation of K+/H+ and Cl-/HCO3- exchange. The anion exchanger AE1 has been
suggested to participate in regulatory cell volume decrease (RVD) (Garcia-Romeu et al.,
1996; Motais et al., 1997). Further studies of the regulatory proteins are likely to reveal
more components.
1.2.3. pH regulation
Intracellular pH (pHi) is tightly regulated to remain within a narrow physiological range in
order to ensure a proper performance of biological processes involved in cell functioning
and cell survival (Busa and Nuccitelli, 1984; Orchard and Kentish, 1990; Isfort et al.,
18
1993). Especially in the intestinal epithelial cells, pHi regulation is challenged by the
continuous transepithelial traffic of ions and other acid/base equivalents (Boron, 1986).
Thus, a single cell utilizes multiple simultaneous pHi regulatory mechanisms, which can
be divided into the acid loaders and acid extruders. In many cell types, parallel Na+/H+ and
Cl-/HCO3- exchanges perform acid-extruding and acid-loading functions, respectively, in
adjusting intracellular pH (Simchowitz and Roos, 1985; Jentsch et al., 1986; Paradiso et
al., 1987; Boyarsky et al., 1988; Stuenkel et al., 1988; Sundaram et al., 1991b). Both
mechanisms are pHi-sensitive and, besides the regulation of basal pHi, Na+/H+ exchange is
thus activated in the recovery from acid load and Cl-/HCO3- exchange in the recovery
from alkaline load (Boyarsky et al., 1990; Sundaram et al., 1991b).
In a human intestinal epithelial cell, selective activation of apical Na+/H+ exchange in
response to the local pHi change generates a local pHi microenvironment that optimizes
the efficient absorptive function most likely by recycling H+ across the membrane
(Thwaites et al., 1999). In addition, tightly regulated extracellular surface pH microclimate
(pHs) is present directly adjacent to the apical membrane of the intestinal epithelial cells
(Rechkemmer et al., 1986; McNeil et al., 1987; Genz et al., 1999) as well as pH
microdomain in the lumen of the colonic crypt (Chu and Montrose, 1995). In a guinea-pig,
bicarbonate, which is mainly secreted by apical Cl-/HCO3- exchanger but also by
SCFA/HCO3- exchanger is responsible for establishing and maintaining the pH
microclimate at the surface of colonic mucosa (Genz et al., 1999).
1.3. Mechanisms of diarrhea
Diarrhea is usually defined as an increase in stool mass, stool frequency, or stool fluidity.
It is classified as acute or chronic according to duration. Acute diarrhea is most frequently
due to different infectious agents (Binder, 1990), while the causes of chronic diarrhea are
more diverse, including irritable bowel syndrome, idiopathic inflammatory bowel disease,
malabsorption syndromes, chronic infections, and idiopathic secretory diarrhea.
Regardless of the primary cause, the major mechanisms leading to the intestinal
dysfunction resulting in diarrhea involve the abnormal amount of osmolytes in the
intestinal lumen, altered intestinal motility, increased net secretion of water and
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electrolytes, and a decrease in the normal absorption of solutes (Fine et al., 1989).
Multiple mechanisms are often involved.
Osmotically active substances can be retained in the intestinal lumen due to generalized
malabsorption or due to specific absorption defects, such as ones caused by disaccharidase
deficiencies (Christopher and Bayless, 1971) or rare inherited disorders like glucose-
galactose malabsorption (Wright, 1993; Martin et al., 1996). Excessive ingestion of poorly
absorbable substances, such as sorbitol, lactulose or divalent ions, also causes increased
luminal osmolality and osmotic diarrhea (Saunders and Wiggins, 1981; Rumessen and
Gudmand-Hoyer, 1988). Enhanced intestinal motility leads to a too rapid transit time of
the intestinal contents and thus disturbs absorption, while decreased motility facilitates
bacterial overgrowth (Fine et al., 1989). Secretory diarrhea results from either enhanced
secretion or a combination of enhanced secretion and the failure of reabsorption (Field et
al., 1989). A typical feature of secretory diarrhea is the fact that no improvement is
achieved by fasting. Bacterial endotoxins, hormones, and detergents are known stimulants
for intestinal secretion. Decreased absorption of ions may be secondary to intestinal
factors, such as decreased surface area and altered epithelial cell dynamics, or due to
primary defects in intestinal ion transporters. Rare causes of diarrhea include congenital
chloride diarrhea and congenital sodium diarrhea that result from inherited defects of the
Cl-/HCO3- exchange and the Na+/H+ exchange, respectively (Holmberg et al., 1977a;
Booth et al., 1985; Holmberg and Perheentupa, 1985). Unabsorbed electrolytes retained in
the intestinal lumen lead to diarrhea mainly by osmotic mechanisms. These rare congenital
disorders with a diarrheal manifestation provide unique knowledge on the importance of
the individual mechanisms for intestinal transport physiology.
1.4. Inflammatory bowel disease (IBD)
Ulcerative colitis (colitis ulcerosa, CU) and Crohn’s disease (CD) are chronic intestinal
inflammatory disorders that have many features in common. Their etiology is unknown,
although infections, immunological changes, genetic predisposition, diet, smoking, and
several other causes have been proposed to participate in their pathogenesis. Both CU and
CD are most common in the Western World with prevalence approximately 1/500 in CU
and 1/1500 in CD. The clinical features in both disorders are highly variable depending on
the site of the disease and the severity of the inflammation, typically including diarrhea
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with or without blood, abdominal pain, mild fever, and general malaise. Crohn’s disease
most often affects the terminal ileum and the right side of the colon, although any site of
the gastrointestinal tract can be involved. CU, on the other hand, is typically limited to
colon and rectum. However, in both CU and CD extraintestinal manifestations may be
detected. Histologically, CD is characterized by the presence of non-caseating granulomas,
transmural infiltration by lymphocytes and plasma cells, fibrosis, and hypertrophy of the
muscularis mucosae. In contrast, in CU inflammation typically affects only mucosa and
submucosa, and the leukocyte infiltrate consists of mononuclear cells and neutrophils as
well as occasional eosinophils and mast cells. (Crawford, 1994; Souhami and Moxham
1994)
In ulcerative colitis, absorption of NaCl accompanied with water is impaired in inflamed
colonic segments. The concentration of sodium and chloride in the stools of CU patients is
elevated and stool pH is lower than normal (Harris et al., 1972; Hawker et al., 1980).
Reduced secretion of bicarbonate coincides with high fecal loss of chloride (Caprilli et al.,
1986), which alone would make it tempting to speculate the participation of apical Cl-
/HCO3- exchanger in the pathogenesis of diarrhea in ulcerative colitis. However, also
electrogenic Na+ transport is mainly lost in inflamed colon, and overall ionic permeability
and the electrical conductance of the colonic mucosa are increased. In addition, the
activity of the basolateral membrane Na+-K+-ATPase in epithelial cells is diminished
(Sandle et al., 1990). Although electrogenic absorption of sodium and chloride has been
shown to be defective in IBD, the role of coupled, electronegative NaCl absorption
mechanism in the pathogenesis of diarrhea has remained unclear. Recent study using a
rabbit model of chronic inflammation established the impairment of coupled
electronegative NaCl absorption in villus cells to result from decreased apical Cl-/HCO3-
exchange activity while apical Na+/H+ exchange activity remained unaffected (Sundaram
and West, 1997). In chronically inflamed rabbit ileum, the Cl-/HCO3- exchange was
inhibited through a diminished affinity for chloride whereas the number of transporters
was not altered (Coon and Sundaram, 2000).
The mechanisms leading to altered epithelial ion permeability and disturbances in active
transport processes in inflamed intestine are unclear. The roles of different inflammatory
mediators have been studied extensively. In addition, cell turnover is enhanced in active
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colitis and thus the proportion of cryptal-like enterocytes that lack the ion absorption
machinery normally present in mature surface epithelial cells is increased (Allen et al.,
1985).
1.5. Congenital chloride diarrhea (CLD)
Congenital chloride diarrhea (CLD, MIM No. 214700) was recognized as a new syndrome
in 1945 by Gamble et al. and Darrow, who described it as “congenital alkalosis with
diarrhea” (Gamble et al., 1945; Darrow, 1945). In 1971 the genetic study of 14 Finnish
and 12 other families showed it to be inherited as an autosomal recessive trait and the
name congenital chloride diarrhea was recommended for the disorder (Norio et al., 1971).
1.5.1. Clinical characteristics
The main clinical feature of CLD is a chronic, life-threatening, watery diarrhea (Holmberg
et al., 1977a). It begins during the prenatal period and leads constantly to polyhyrdamnios
often associated with premature birth. Birth weights and lengths are normal for the
gestational age (Holmberg et al., 1977a). The babies have distended abdomens and lack
meconium, which may lead to a suspicion of intestinal obstruction and an unnecessary
laparotomy (Langer et al., 1991). Voluminous diarrhea that may be mistaken as urine
causes an excessive loss of weight with severe dehydration in the first few days of life, and
the babies fail to thrive. Also hypochloridemia and hyponatremia develop rapidly,
followed later by hypokalemia, hyperbilirubinemia, and metabolic alkalosis (Norio et al.,
1971; Holmberg et al., 1977a; Holmberg, 1986). Blood sodium levels, however, normalize
after the neonatal period. In addition to a high chloride concentration, a low concentration
of bicarbonate and a low pH is detected in stools, and urine is Cl--free due to the volume
depletion (Holmberg et al., 1977a). Most untreated patients die during the first months of
their life. Some do survive without treatment but suffer from chronic hypochloridemic
dehydration causing retarded growth and development. Furthermore, chronic
hypovolemia, together with acute insults of dehydration and anuria in patients with
inadequate substitution, leads to an early kidney failure which is histologically
characterized by juxtaglomerular hyperplasia, hyalinized glomeruli, calcium deposits, and
vascular changes similar to those in hypertension (Holmberg et al., 1977b). Adequate
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treatment corrects all electrolyte and hormonal abnormalities and prevents the
development of renal lesions (Holmberg, 1986). Properly treated children are therefore
likely to grow and develop normally.
1.5.2. Diagnosis and treatment
A history of polyhydramnios and prematurity together with persistent watery diarrhea
should lead to a suspicion of congenital chloride diarrhea. If electrolyte disturbances are
corrected, a detection of high fecal chloride content (over 90 mmol/l) verifies the
diagnosis (Holmberg, 1986). After the neonatal period, the fecal Cl- concentration exceeds
the sum of the Na+ and K+ concentrations, although Cl- concentration may be low due to
severe dehydration and disturbed electrolyte balance (Holmberg, 1978). Ultrasonographic
diagnosis already during the prenatal period is possible on the basis of distended loops of
the intestine (Kirkinen and Jouppila, 1984).
The aim of the treatment is to maintain a normal fluid and electrolyte balance, which is
achieved simply by the continuos supplementation of the diarrheal loss of water, Cl-, Na+,
and K+. In the case of newborns, the supplementation is carried out intravenously, while
older children and adults take balanced supplement solutions orally (Holmberg, 1986).
Oral administration is based on passive diffusion of electrolytes through the more
permeable small intestinal epithelium. The dosages of NaCl and KCl are adjusted to
maintain normal pH in blood and Cl- excretion into urine (Holmberg, 1986). Although
diarrhea continues as long as the fluid and electrolyte balance remains normal, secondary
consequences are prevented.
1.5.3. Intestinal pathophysiology
In CLD, the basic defect is the impairment or absence of an active ileal and colonic Cl-
/HCO3- exchange mechanism (Holmberg et al., 1975). The defect in chloride absorption
causes hypochloridemia and large amounts of chloride are retained in intestinal lumen,
which leads to diarrhea by osmotic mechanisms. Simultaneous bicarbonate secretion is
absent, leading to intracellular alkalinity and acidification of intestinal content. Although
the Na+/H+ exchanger itself is intact, both of these further inhibit sodium absorption
through it (Holmberg, 1978). Hyponatremia and chronic hypovolemia lead to secondary
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hyperaldosteronism and high renin activities that further enhance the loss and depletion of
K+, thus increasing metabolic alkalosis (Holmberg, 1978).
1.5.4. Epidemiology and genetics
Since the first description of CLD by Gamble et al. and Darrow in 1945, approximately
200 CLD cases have been reported worldwide, about 50 of them in Finland (Norio et al.,
1971, 1973; Holmberg et al., 1977a; Holmberg, 1986). Other high-frequency areas include
Poland, Saudi Arabia, and Kuwait (Tomaszewski et al., 1987; Lubani et al., 1989; Shaltout
et al., 1989; Khan and Yaish, 1992; Kagalwalla, 1994). The highest incidences have been
reported in the Arabic countries where consanguineous marriages are common. In Saudi-
Arabia, CLD is estimated to occur 1 in 5,000 newborns (Kagalwalla, 1994) and in Kuwait
even 1 in 3,200 (Badawi et al., 1998). In the eastern provinces of Finland, the incidence is
1 in 20,000 births, while in Poland the disorder is much more rare with an estimated
incidence of 1 in 200,000 (Höglund et al., 1998). Furthermore, sporadic patients have been
described in many different ethnic backgrounds and populations, including almost all
European countries, the United States and Canada, Argentina, many countries in Asia and
the Middle East, and Australia. Many patients are likely to remain unrecognized and die in
early infancy.
The hunt for the CLD gene started by screening three candidate genes for mutations and a
subsequent linkage mapping of the CLD gene close to a known chloride transporter, the
cystic fibrosis transmembrane conductance regulator (CFTR) gene in chromosome 7q
(Kere et al., 1993). The genetic linkage disequilibrium study in the Finnish founder
population refined the localization of the CLD gene (Höglund et al., 1995), and a physical
map was constructed in order to identify the gene responsible for congenital chloride
diarrhea (Höglund et al., 1996). The physical map consisted of 51 YAC clones that
covered 2,7 Mb around marker D7S496. Four known genes (DRA, PRKAR2B, LAMB1,
and DLD) and 13 CpG islands corresponding most likely to yet unknown genes were
established to that region (Höglund et al., 1996). The DRA (for down-regulated in
adenoma) gene localized to the most critical region suggested by the linkage
disequilibrium mapping (Höglund et al., 1995). It was initially cloned as a putative tumor
suppressor gene due to its down-regulated expression in colon adenomas and carcinomas
(Schweinfest et al., 1993). Furthermore, its expression was limited to intestinal epithelium
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(Schweinfest et al., 1993) and it demonstrated protein homology to known sulfate
transporters across a large taxonomic span. Both the DRA gene and another gene,
PRKAR2B, map within 450 kb of marker D7S496. PRKAR2B encodes a regulatory
subunit for protein kinase A (Solberg et al., 1992). They were both concluded to be
positionally and functionally relevant candidate genes (Höglund et al., 1996), although the
possible participation of the DRA gene in anion transport made it an especially attractive
candidate for CLD.
1.6. Diastrophic dysplasia sulfate transporter (DTDST)
Diastrophic dysplasia (DTD, MIM No. 222600) is an autosomal recessive
chondrodysplasia characterized by short-limbed dwarfism, spinal deformation, and
generalized dysplasia of the joints (Walker et al., 1972). A new linkage disequilibrium
approach was successfully utilized in the search for the gene responsible for DTD, and a
novel gene was designated as the diastrophic dysplasia sulfate transporter, DTDST, was
cloned. The northern analysis of the Finnish DTD patient samples demonstrated markedly
reduced expression of the DTDST gene. Its identity as the gene responsible for diastrophic
dysplasia (DTD) was confirmed by identifying point mutations in DTD patients from
other populations (Hästbacka et al., 1994). Furthermore, fibroblasts from a DTD patient
demonstrated a defective sulfate uptake, which gave further functional support. Since then,
three more chondrodysplasias, achondrogenesis IB (ACG1B; Superti-Furga et al., 1996),
atelosteogenesis type II (AO2; Hästbacka et al., 1996), and recessive multiple epipyseal
dyplasia (rMED; Superti-Furga et al., 1999), have been shown to result from mutations in
the DTDST gene and thus to be allelic to diastrophic dysplasia.
Surprisingly, the northern analysis showed DTDST expression in all tissues studied
although clinical abnormalities in DTD are restricted to cartilage and bone (Hästbacka et
al., 1994). However, later northern analysis of rat tissues has suggested a more restricted
expression pattern including only calvaria and intestine (Satoh et al., 1998). As the
DTDST gene was cloned, it was shown to be homologous to the known rat sulfate
transporter Sat-1 (Bissig et al., 1994) and also to the recently cloned putative tumor
suppressor gene DRA (Schweinfest et al., 1993). Functional study has established that
both human and rat DTDST cRNA injected to Xenopus oocytes induces Na+-independent
sulfate transport that can be inhibited by extracellular chloride and bicarbonate (Satoh et
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al., 1998). DTDST was suggested to function as a SO42-/Cl- antiporter. Similar activity has
also been detected using chondrocytes. Studies using DTD patient fibroblasts and
chondrocytes have demonstrated defective sulfation of proteoglycans (Rossi et al., 1996).
Sulfate is an important constituent of highly sulfated macromolecules, like mucins and
proteoglycans, produced by the cells. Inorganic sulfate available for sulfation in the
intracellular biosynthesis of macromolecules is supplied by SO42- transport, but also by
catabolizing sulfur-containing amino acids (Elgavish and Meezan, 1991). The ability of
cells to use sulfated amino acids as the alternative sources for sulfation reactions at low
extracellular concentrations of free inorganic sulfate is variable. Although Chinese
hamster ovary cells and mouse 3T3 fibroblasts synthesize properly sulfated
macromolecules in the absence of exogenous sulfate (Esko et al., 1986; Keller and Keller,
1987), study on human chondrocytes deficient with DTDST has shown only partial ability
to compensate for the lack of inorganic sulfate in their macromolecular biosynthesis
(Rossi et al., 1996), leading to severe chondrodysplasia.
1.7. Human gene nomenclature
The significance of a standardized, consistent nomenclature was generally recognized to
get the most (consistency and searchability) out of the multiple databases used for
different purposes. The Human Gene Nomenclature Committee (HGNC) is a
subcommittee of The Human Genome Organization (HUGO) working on approving and
implementing human gene names and symbols. The aim is that the approved symbols are
always unique and no two genes have the same name or symbol. Some journals (for
example Nature Genetics, Genomics etc.) insist on the use of approved gene symbols. The
confusing disconcordance of gene names and symbols is partly due to researchers’ desire
to give their own name for the gene they have discovered and published. Recently gene
nomenclature has been further challenged by the development of high-throughoutput
sequencing techniques and data provided into electronic databases throughout the world.
There has also been a need for a system for naming members of a gene family. Several
systems are in use, but probably the most frequently used is the symbol stem followed by
a number assignment (for example SLC26A1, SLC26A2, SLC26A3, etc.), which makes
expanding easy when related genes are discovered. For the system to function the gene
family has to be well established and characterized. Guidelines for Human Gene
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Nomenclature (1997) was published in order to help each gene symbol to be unique and
appropriate (White et al., 1997). However, scientists are responsible for a new gene
symbol to be verified in the HUGO Nomenclature Committee (see
http://www.gene.ucl.ac.uk/nomenclature/).
Some basic concepts according to the nomenclature guidelines (White et al., 1997) follow:
1. A gene symbol may be used to designate a clearly defined phenotype shown to be
inherited as a monogenic mendelian trait (Example: CLD).
2. A gene symbol may be used to designate a cloned segment of DNA with a sufficient
structural, functional, and expression data to identify it as a transcribed entry
(Example: DRA).
3. Gene family members should be made recognizable in order to facilitate retrieval of
related data from databases. This is often done by using the consistent gene symbol
stem and a numbering system (Example: SLC26A1, SLC26A2, SLC26A3, etc.).
The suggested model for using different gene symbols for the same gene is to use the
approved gene symbol alongside the alias favored by the author in the title and/or abstract,
and either the approved symbol or alias can then be used in the rest of the paper without
further confusion. The challenge for meaningful gene names and symbols is novel genes
without sufficient characterization. Renaming also happens. It is usual for the gene symbol
to change when the gene product or function responsible for the clinical disorder is
identified. Often a gene symbol based on the product or function already exists and usually
supersedes the symbol derived from the clinical disorder.
The gene responsible for congenital chloride diarrhea will be called the CLD gene
throughout this thesis, the oldest designation being the CLD gene for the defined
recessively inherited CLD phenotype. In addition, we find that the CLD gene is the
functionally correct designation for the suggested intestinal anion transporter.
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1.8. Methods for genomic and expression analysis of a disease gene
1.8.1. Mutational screening
Four traditional approaches for identifying human disease genes are functional cloning,
positional cloning, position-independent candidate gene strategy, and positional candidate
gene strategy. Identification of the disease gene using functional cloning relies purely on
the available biological information, such as the pathogenesis of the disease or the
biochemical fuction of the protein. In positional cloning, the disease gene is isolated on the
basis of its location in the genome (Collins 1992, 1995). The subchromosomal location of
the gene may be determined by genetic linkage analysis, by loss of heterozygosity
screening, or by chromosomal abnormalities. No knowledge of the subchromosomal
location is needed in position-independent candidate gene approach (Collins 1995). In this
method, a candidate gene is suggested by homologous genes, which code proteins in
similar human phenotypes, or by homologous genes related to an animal phenotype
showing similarity to a human disorder. The positional candidate gene approach combines
positional cloning with a candidate gene strategy (Ballabio 1993). Due to the Human
Genome project and recent advances in identification of cDNAs throughout the human
genome, it is becoming the most popular method to identify disease genes.
When a candidate gene or genes are found they need to be analyzed for the presence of
putative disease causing mutations. Mutation screening usually starts from the coding
region of the gene, although some mutations affecting the function are located outside the
coding region. After screening the coding region with a negative result, the clinical picture
of the patient should be checked once more to make sure that the condition is not different
from the one you are studying. Then mutation screening can be extended to the putative
promoter region or to other areas containing gene regulatory elements.
Multiple methods are available for the mutational screening of the gene of interest. In a
research laboratory, both availability and suitability often determine the methods to be
chosen. The number of samples to be analyzed, the size and number of candidate genes,
the expected nature of mutations, and both the speed and accuracy of the method will
affect the choice. Much time is not wanted to be spent on optimizing the test at this stage.
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Direct sequencing
A widely used method for screening novel mutations in patient samples is the direct
sequencing. It has become popular after automated fluorescence sequencers have provided
a fast and reliable option for more laborious manual sequencing methods (Smith et al.,
1986). If genomic PCR is not possible, sequencing can be performed with RT-PCR
fragments (I). However, a high quality template is needed to avoid investigating sequence
artifacts. Direct sequencing detects all sequence changes, which simultaneously become
fully characterized. The possible disease causing nature of the detected mutations has to be
verified with further study. A major disadvantage of direct sequencing with an automated
sequencer is its high cost, which makes cheaper methods more attractive, especially when
scanning large genes with multiple exons for mutations. Often sequencing is used as a
secondary method to confirm and characterize the mutations detected by some other
methods such as SSCP, DGGE or DHPLC.
Single-stranded conformational polymorphism (SSCP) and heteroduplex analysis
The SSCP (Orita et al., 1989; Sheffield et al., 1993) and heteroduplex gel mobility are
frequently used simple, inexpensive methods suitable for mutational screening. They can
be performed simultaneously on a single gel. In SSCP, after denaturation amplified DNA
samples are separated under non-denaturing conditions in a polyacrylamide gel. This
allows single-stranded fragments to fold up and form a structure that is stabilized mostly
by hydrogen bonding. The electrophoretic mobility of these structures will depend on
chain length and on conformation determined by the DNA sequence. Sequence variations
are then detected as mobility shifts in the gel.
Heteroduplexes are formed by denaturing the amplified DNA sample and allowing it to
cool down slowly. Heteroduplexes have often altered electrophoretic mobility under
nondenaturing conditions. Both SSCP and heteroduplex gel mobility are suitable for
analyzing short fragments (∼200 bp) and numerous control samples are needed to reveal
differences from wild-type pattern. The mutation detection sensitivity of these methods is
limited and they don’t reveal the position or nature of the sequence change causing the
mobility shift. Sequencing is needed to confirm mutations.
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Other methods also rely on the altered properties of heteroduplexes. Denaturing gradient
gel electrophoresis (DGGE) is based on the unique melting temperature of DNA duplex.
Amplified fragments are separated in a chemical (DGGE) or temperature gradient gel
(TGGE). The mobility of the fragment changes significantly when it denatures. This
method requires the design of special primers containing GC extension (∼40 bp) called a
GC-clamp at their 5’-end. 100% sensitivity has been reported with 2D-DGGE (Dhanda et
al., 1998), but even the basic version is sensitive.
Denaturing high performance liquid chromatography
Heteroduplex formation in amplified samples is utilized by denaturing high performance
liquid chromatography (DHPLC) as well (Oefner and Underhill 1995; Underhill et al.,
1997; Liu et al., 1998). PCR products are subjected to ion-pair reverse-phase liquid
chromatography under partially denaturing conditions. Heteroduplexes display reduced
column retention time relative to their homoduplex counterparts and the elution profiles
for the samples containing heteroduplexes differ from those containing homozygous
sequence. A maximum sensitivity is achieved with fragments of 150-550 bp, although
fraqments up to 1500 bp can be analyzed (O’Donovan et al., 1998). The most advantages
of DHPLC include semi-automation of the method, speed of analysis, and flexibility of
fragment size. Thus, it is a highly sensitive and reliable method for mutational screening.
Chemical and enzymatic cleavage of mismatch (CCM, ECM)
A sensitive method for identifying sequence changes in larger fragments (up to 1 Kb) is
the cleavage of mismatched bases. It can be performed either chemically (CCM; Cotton et
al., 1988) or enzymatically (ECM; Youil et al., 1995), but enzymatic cleavage is more
convenient due to the toxicity of chemicals. Its advantage lies in the fact that the sequence
change can be localized on the basis of the size of the fragments generated.
Protein truncation test (PTT)
PTT is a sensitive method for the detection of protein truncating mutations. Its major
advantage is that, in addition to detecting mutations, it also demonstrates their deleterious
effects on the functional level. Other benefits include a low false-positive rate and
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localization of the mutation. In a recent modification of PTT, an N-terminal tag has been
added to the forward primer, which facilitates the detection of correctly initiated proteins
only (de Koning Gans et al., 1999). Overall, PTT is sensitive and efficient in screening
disease genes in which a significant proportion of mutations are known to be truncating,
for example in tuberous sclerosis (TSC1, Benit et al., 1999), neurofibromatosis (NF1,
Heim et al., 1995), and breast cancer (BRCA1, Lancaster et al., 1996a; BRCA2, Lancaster
et al., 1996b).
Nature of the sequence variation
After a sequence change in the coding region of a gene is found its possible pathogenicity
has to be verified. The nature of the sequence variation and its genomic context can give
some clues to its possible pathogenicity. Whole gene deletions are certain to destroy gene
function. Also small deletions as well as insertions in the coding region are likely to be
pathogenic, especially if they introduce a frameshift. Nonsense and frameshift mutations
cause premature termination of translation and thus truncated polypeptides, which
obviously destroys or severely affects the function. Mutations within 5’ or 3’ consensus
splice sites of introns are likely to affect the splicing and the function of the gene. If a
missense mutation occurs in the region of a known structure or important function it is
more likely to be pathogenic for the function. Mutations affecting evolutionary conserved
residues or causing non-conservative amino acid substitutions are more prone to affect the
function. The pathogenic nature of the mutation is supported by an independent detection
of the mutation in an unrelated patient with the same disease and the failure to show such a
mutation in a large number of normal controls. Also separate mutations in the same gene
in different families affected by the disease make pathogenicity more probable. Further
support is provided by the cosegregation of the mutation and disease phenotype through a
family pedigree. Finally, the effect of the mutation for the function of the protein can be
studied in vitro to demonstrate that a mutant protein in vitro shares the same biochemical
properties and characteristics as its in vivo counterpart.
1.8.2. Testing for specified mutations
After the sequence variation in the candidate gene has been found, the verification of its
pathogenicity often starts with screening a large number of normal control chromosomes
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for the presence of the change. In addition, screening is necessary in studying other
patients with diseases with one particular sequence change or a limited number of specific
mutations, and in studying family members of affected individuals with a specified
sequence change. Any of the methods suggested for mutational detection can also be used
in screening the specified mutations. The optimal screening method is fast, easy to
perform, sensitive, and economical.
The presence of most deletion and insertion mutations can be detected directly after gel
electrophoresis due to the altered size of the designed PCR amplification fragment (I, III).
When mutation generates a novel restriction enzyme recognition site or causes loss of an
existing one, a simple screening method based on restriction enzyme digestion after PCR
amplification can be designed (I, III). An artificial restriction site to detect mutation can
also be introduced by PCR mutagenesis. PCR-OLA (oligonucleotide ligation assay;
Landegren et al., 1988) is a suitable method for automated mutation detection. After PCR-
amplification of the template sequence, two oligonucleotides are hybridized to adjacent
sites in the target, followed by the covalent ligation of the oligonucleotides in case of a
perfect match. The method has been further developed for simultaneous screening of two
mutations in a single microtiter plate well (Romppanen and Mononen, 2000).
Heteroduplex instability is utilized in allele-specific oligonucleotide (ASO) hybridization.
A short ASO probe will hybridize to target sequence only if base complementarity is
perfect between them and even a single nucleotide substitution renders heteroduplex
unstable (Conner et al., 1983; Lau and Tolan, 1999). The PCR equivalent of ASO
hybridization is called allele specific amplification (ASA; Newton et al., 1989). It is based
on the dependence of PCR amplification on correct base pairing at the 3’end and thus
utilizes oligonucleotide primers that are designed to differ at the very 3’ terminus.
A real-time PCR method, based on the continuos monitoring of samples during PCR, was
developed for the analysis of PCR kinetics (Higuchi et al., 1992). The improved real-time
PCR method utilizes the 5’--> 3’ exonuclease activity of Taq DNA polymerase and a
labelled probe (Holland et al., 1991). The probe anneals to a specific amplification product
and is cleaved by the 5’ nuclease activity of the polymerase as the new DNA strand is
extended from the upstream primer. The cleavage releases the separate nucleotides
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containing the label. Recently, the development of new fluorescent techniques for real-
time PCR has provided new tools for the detection of specific sequence changes. Melting
curve analysis of a PCR product provides a good system for the detection of single-
nucleotide polymorphisms (Lay and Wittwer, 1997).
Solid phase minisequencing (or single-nucleotide primer extension; Syvänen et al., 1990;
1990) is a method developed for detecting single-nucleotide variations. In this method, a
detection primer anneals to the target nucleic acid directly adjascent to a variable
nucleotide. A DNA polymerase incorporates a labeled nucleotide complementary to the
variable nucleotide to the 3’ end of the detection primer. An advantage of solid phase
minisequencing is its excellent ability to discriminate between heterozygous and
homozygous genotypes. Recently, it has been shown to be useful in detecting a large and a
small deletion in addition to single-nucleotide changes in an oligonucleotide array format
(Pastinen et al., 1997).
1.8.3. From sequence to function
After the gene and mutations responsible for a certain disease or phenotype are found, a
whole new field will open up for further study. The next goal is to understand the function
of the protein and its physiological role in the organism as well as pathophysiology
resulting from its defective function. The function of a specific gene product involves its
structure, biochemical function (such as substrate specificity or cofactors), interaction with
other macromolecules, cellular localization, and possible targets, as well as the pathway
and the organs it affects, and the physiological role it plays in the total organism.
Sometimes the mechanisms underlying certain disease or a pathological phenotype are
well characterized, which aids in directing expression and functional studies (Holmberg et
al., 1986). The phenotype can present some clues to the expression sites or affected
pathway. Often a good starting point for expression studies is the affected organs, where
the expression of the gene and protein is probable. A novel gene can be connected to a
certain pathway or complex based on the similar phenotype with other pathway members
(Monreal et al., 1999). Computational methods are fast and highly useful in analyzing
amino acid sequence in order to establish a possible functional linkage with an already
characterized protein. Overall amino acid homology with a known human protein suggests
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a resembling structure and biochemical function (Lohi et al., 2000). Although no human
homology can be detected, amino acid sequence homology may be identified with some
other organism like yeast, which may then help in defining the function of the human
sequence (Oliver, 1996). Computational amino acid sequence analysis can reveal domains
or profiles that are common with already characterized proteins and known to perform or
participate in specific functions (Ezer et al., 1999; Furusawa et al., 2000). Even if no
homology or functional linkage with known protein or structure can be assigned,
analyzing the amino acid sequence can provide useful information of the protein. For
example, the hydrophobicity profile may reveal membrane-spanning segments in the
sequence. Despite extensive computational analysis, no expression pattern or biochemical
function can, however, be assigned for the majority of novel proteins.
1.8.4. Gene and protein expression
The expression can be studied both at the level of mRNA and protein, the basic difference
being that mRNA-based methods measure the expression intermediate and protein-based
methods the final functional expression product. A major advantage of some protein-based
methods is the possibility to detect post-translational modifications, cellular localization,
and protein complexes. However, mRNA-based methods are often easier and provide
useful information about the state of the cell and gene activity. The disadvantage of most
methods used for expression studies is that they do not allow quatitation of the expression.
Northern blot analysis
One of the first expression studies performed on the gene of interest is usually northern
blot hybridization. A genomic or cDNA fragment is labeled and used as a probe to study
the RNA expression of the gene. The probe is hybridized against membrane, various lanes
of which contain samples of RNA (total or mRNA) from a variety of sources. Sample
RNA can be isolated from affected and normal individuals, which allows the detection of
the effect of the mutation on RNA levels (Hästbacka et al., 1994). A frequently used form
of northern blot contains RNA in different lanes, which has been isolated from a variety of
normal adult tissues. Also embryonic or fetal tissues can be utilized to determine
expression at different developmental stages or in different cell types. Hybridization
reveals the gross tissue expression pattern of the transcript as well as its relative
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abundance in different tissues. RNA separated in a gel is size-fractionated, which
facilitates the estimation of the size of transcripts and allows the detection of differently
sized isoforms that are visible as multiple bands in one lane (Ranta et al., 1999).
Sometimes RNA dot blots are used instead of gel separated RNA blots to allow the
evaluation of a broader spectrum of samples in one experiment (Gilligan et al., 1999).
Reverse transcriptase polymerase chain reaction
Conventional reverse transcriptase polymerase chain reaction (RT-PCR) is a fast and
sensitive method for obtaining the gross expression pattern of the gene. It can be used to
study the presence of transcript or to detect its isoforms in different tissues and cell types
together with their rough relative abundancies. It is most useful when the amount of
template is limited, like in preimplantation embryos (mouse model screening) or in single
cell analysis. Like northern blot analysis, RT-PCR detects mRNA in tissue homogenates.
Quantitative polymerase chain reaction
A real-time polymerase chain reaction (PCR) system (see p. 31) can be utilized for
quantitative analysis of a gene expression. The quantitative PCR utilizes the theoretical
relationship between the amount of starting target sequence and the amount of PCR
product at any given cycle. Measurements are performed in the exponential phase where
reaction components are not limiting. Both DNA and RNA (RT-PCR) can be used as a
starting material. Relative quantitation of a gene expression can be achieved using either
the comparative CT method or the standard curve method. In comparative CT method, the
number of the target gene copies is normalized to an endogenous reference gene. An
alternative method relies on the use of a standard curve containing serial dilutions of a
specific standard sample.
Tissue in situ hybridization
Tissue in situ hybridization can be used when specific nucleotide sequences are detected in
morphologically preserved tissues and cells (Gall and Pardue, 1969; John et al., 1969;
Willcox, 1993). A thin tissue section mounted on a microscope slide is hybridized with a
suitable probe. Double-stranded cDNA, an antisense RNA, or an oligonucleotide can be
used as a probe, but highest sensitivity is achieved with an antisense riboprobe which
35
hybridizes specifically to the sense mRNA of the gene (Cox et al., 1984). Probes are
labeled using radioisotopes, fluorochromes, or chemicals. Visualization and analyzing the
hybridization results depend on the label used in the probe. mRNA tissue in situ
hybridization allows the spatial and temporal analysis of the gene expression in various
physiological and pathological conditions, as well as during development. However, in
situ hybridization allows no quantitation of RNA expression levels unless an image
analysis with appropriate software is used (Jonker et al., 1997).
Immunoblotting
Immunoblotting is used to detect a certain protein in a protein mixture, such as tissue or
cell culture lysates, and to estimate the size of the denatured protein. The amount of the
protein can be estimated by comparing the staining intensity of an unknown protein to the
staining intensity of protein standards. Proteins are separated according to their size under
denaturing conditions in SDS-PAGE gels. After electrophoresis, proteins can be stained
using an appropriate stain, e.g. Coomassie blue (Wilson, 1983), or silver staining (Switzer
et al., 1979). However, the fractionated proteins are usually transferred from the gel to a
membrane which is then either stained or exposed to a protein-specific antibody (western
blotting). Ponceau S staining of the membrane is transient, which makes it possible to first
stain all proteins in the membrane and then continue with exposing to a specific antibody.
Immunohistochemistry
At protein level, an equivalent to the mRNA tissue in situ hybridization is
immunohistochemistry, which is used to localize proteins in specific cell types of different
tissues or in other multicellular structures. Similarly, antibodies are also used to detect
proteins in single cells (immunocytochemistry) in order to reveal subcellular localization
of the protein. Instead of a nucleic acid probe, a specific mono- or polyclonal antibody or
antiserum is utilized to recognize specific epitopes of the protein. Recent advances in
fluorescence tehcnology have enabled the development of multicolour immunostaining to
evaluate co-localization of two or more antigens in an objective manner and also dual
immunohistochemical and mRNA in situ hybridization detection of the same tissue
section (Zaidi et al., 2000). The fluorescent methods are also more suitable for quantitative
computerized image analysis (Mosedale et al., 1996).
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2. AIMS OF THE STUDY
The principal goal of this study was to provide basic information about the major intestinal
Cl-/HCO3- transporter and pathophysiology of congenital chloride diarrhea.
The specific aims were:
1. to identify the CLD gene (I)
2. to determine the genomic structure of the CLD gene (II)
3. to characterize mutations in CLD patients (I, III)
4. to establish the expression pattern of CLD in human tissues (I, IV)
5. to study the expression of closely related anion transporter DTDST in human tissues
and compare its colonic expression with that of CLD (IV, V).
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3. MATERIALS AND METHODS
All parts of the study were approved by the Ethics Committee of the Department of
Medical Genetics, Haartman Institute, University of Helsinki. The clinical phenotype of
all patients was characterized by a profuse watery diarrhea with a high chloride content
typical for CLD.
3.1. Mutation detection
Total RNA for the RT-PCR was extracted from lymphoblast cell lines of CLD patients.
First strand synthesis of the cDNA was performed using M-MLV reverse transcriptase and
random hexamers. Two rounds of PCR were performed using either nested or the same set
of primers. The products were separated by electrophoresis, excised, and purified.
Sequencing reactions were done using specific primers and employing dye-terminator
chemistry and an automated sequencer (ABI373A). After the identification of V317del
mutation, its presence in controls was screened by detecting the 3-bp deletion in the 81-bp
genomic PCR fragment using PAGE and silver staining.
Also H124L and 344delT mutations were identified by the direct sequencing of a 133-bp
genomic PCR fragment. The screening of 344delT was based on the detection of a 1-bp
deletion in 133-bp genomic PCR fragment using PAGE and silver staining while H124L
generated a novel restriction site for enzyme HinfI (GANTC) that was utilized in the same
133-bp genomic PCR fragment. The digestion products of either the 49-bp and 84-bp or
the undigested 133-bp fragment were separated in PAGE and visualized by silver staining.
Screening for T to G transversion at position 921 was based on the generation of a novel
restriction site for BslI (CCNNNNNNNGG) and a loss of site for restriction enzyme
Tsp45I (GTC/GAC). Genomic PCR fragments approximately 560 bp in size were digested
with both restriction enzymes and separated with agarose gel electrophoresis.
3.2. SSCP analysis of mutations
PCR amplification was performed using intronic exon specific primers and genomic DNA
as a template. After amplification, 5 µl of the 75 µl PCR assay was added to bromophenol-
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blue and formamide containing stop solution. After denaturation, samples were separated
on a non-denaturing polyacrylamide gel (FMC) and visualized by silver staining. PCR
fragments demonstrating a mobility shift in SSCP analysis were purified and sequenced
using an automated sequencer.
3.3. Genomic cloning
We constructed a genomic library using DNA from a CLD patient with paternal
uniparental disomy who was homozygous for all loci in chromosome 7 (Höglund et al.,
1994). Genomic DNA was partially digested with Sau3AI, and fragments larger than 15
kb were ligated into the phage vector EMBL3 and packaged. The library was screened by
plaque lift hybridization with a 32P-labelled mixed human DRA cDNA probe. After
hybridization, filters were washed and autoradiography was performed on X-ray films at
+4 ºC overnight.
Positive genomic phage inserts were examined by dot blot hybridization analysis using
each of the five CLD cDNA probes separately. Two of the phages that were found to span
most of the CLD gene were purified, partially digested with Sau3AI, and subcloned.
Insert-positive subclones were identified by hybridization utilizing the same set of CLD
cDNA probes and sequenced by cycle sequencing using both universal vector primers and
an internal primer designed for the pUC118 cloning site. CLD-specific primers were also
used to sequence from the exons into the introns using genomic phage clones as templates.
With this, most of the intron-exon boundaries of the coding region of the CLD could be
established.
3.4. cDNA probes
Five overlapping human DRA cDNA probes, a 501-bp fragment (nt 154-654), a 620-bp
fragment (nt 601-1220), a 614-bp fragment (nt 1089-1702), a 622-bp fragment (nt 1650-
2271) and a 582-bp fragment (nt 2217-2798) were prepared by PCR amplification of a
human colon cDNA library. The primers were 18-24 bp in length corresponding to the
ends of the amplified fragment. When preparing the 501-bp fragment, polymerase was
added to the reaction during the first denaturation. PCR fragments were excised from
agarose gel and used as templates for hybridization probes.
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3.5. Primers, PCR assays and sequence analysis
CLD-specific primers were designed on the basis of the published human DRA cDNA
sequence (GenBank number L02785). The primers were used for amplifying cDNA
fragments for probes, for genomic PCR, and for sequencing. The nucleotide sequence
obtained from the genomic regions adjacent to exon borders enabled us to develop intronic
primers for amplifying each exon of the CLD gene separately (II). Exon specific PCR
assays were either analysed in agarose and PAGE gels or purified and sequenced. The
templates for sequencing included human CLD positive phage clones, YAC DNA, P1
obtained from a commercial library, and genomic DNA from a Finnish patient and
controls. Genomic PCR fragments were excised from agarose gel, purified, and used
together with CLD-specific sequencing primers to complete the sequence obtained from
genomic clones. In this way, all the remaining intron-exon boundaries of the coding region
of the CLD could be established.
All DNA sequencing was automated (using an ABI-373A), with sequence editing and
analysis done by the Auto-assembler software (Perkin-Elmer) and GCG programs,
respectively (Program manual for the Wisconsin package, Version 8, August 1994;
Genetics Computer Group, Madison, WI). For the analysis of the putative promoter
region, the compiled genomic sequences were subjected to analysis using the
MatInspector Release 2.1 (Quandt et al., 1995).
3.6. Large-scale sequencing
To determine the full gene structure, the genomic DNA sequence of two bacterial
artificial chromosomes (BACs), H_RG013F03 and H_RG364P16, known to encompass
the gene (see http://www.genet.sickkids.on.ca/chromosome7/), were analysed. Although
the sequence of these clones was not completed at the time of this study
(http://genome.wustl.edu/gsc/human/chrom7.html/), it was sufficient to allow us to align
the complete cDNA to the genomic sequence. This was accomplished by establishing a
BLAST database containing the BAC DNA sequences using GCG and aligning CLD
cDNA to the genomic DNA sequence within the database (the BLAST results were
filtered with MSPcrunch).
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3.7. Northern hybridization
Commercially available Multiple Tissue Northern Blot (Clontech) was hybridized with a
32P-labelled 622-bp (nucleotides 1650-2271) CLD cDNA fragment that was generated by
PCR amplification using human colon cDNA library as a template. After hybridization,
filters were washed and autoradiography was performed on X-ray films at +4 ºC.
3.8 Tissues
Formalin fixed, paraffin-embedded archival specimens from adult patients were obtained
from the Department of Pathology, Haartman institute, University of Helsinki (adult
tissues) and the Department of Pathology, University of Oulu (fetal tissues). All
inflammatory intestinal samples represented an active, ulcerative phase of the diseases and
were from adult patients. All fetal material originated from medical abortions.
3.9 In situ hybridization
A 622-bp fragment corresponding to positions 1650-2271 of the CLD cDNA (GenBank
number L02785) and a 549-bp fragment corresponding to positions 1422-1970 of the
DTDST cDNA (GenBank number U14528) were generated by polymerase chain reaction.
These fragments were designed with a T7 RNA polymerase promoter at the 3' end and
SP6 RNA polymerase promoter at the 5' end. Both sense and antisense probes were
transcribed from the same PCR product. Both CLD and DTDST antisense and sense RNA
probes were labeled with alpha-35S-UTP. As previously described in detail (Prosser et al.,
1989), deparaffinized tissue sections were digested with proteinase K and treated with
acetic anhydride in triethanolamine buffer. After hybridization at 52°C overnight, the
slides were washed under stringent conditions, including RNase A, and exposed to LM-1
emulsion for 21 to 50 days. The slides were developed and counterstained with
hematoxylin and eosin. Normal colon samples known to be positive were used as controls
in each experiment and a sense RNA probe was used as a negative control.
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3.10. Immunohistochemistry
Antisera were raised in rabbits against synthetic peptides, corresponding to nucleotides
2375-2416 of the CLD cDNA sequence (GenBank number L02785) and nucleotides 199-
244 and 2095-2146 of the DTDST cDNA sequence (GenBank number U14528). Peptide
synthesis and antibody production were purchased from Research Genetics (Huntsville,
Alabama, USA). Immunohistochemistry was performed on serial sections of those used
for in situ hybridization.
For the detection of the CLD protein the peroxidase-antiperoxidase technique was
performed using an automatic immunostaining device (Ventana Medical Systems) and
Ventana kits. For the detection of the DTDST protein the peroxidase-antiperoxidase
technique was performed using the Vectastain Elite ABC Kit. Diaminobenzidine (DAB)
was used as the chromogenic substrate. Preimmune sera were used as a negative control
for parallel sections.
3.11. Western blotting
The specificity of the antibodies was demonstrated by Western blotting using
homogenized human colon epithelium (CLD) or osteosarcoma tissue (DTDST). Denatured
proteins were separated in SDS-polyacrylamide gel and blotted using standard protocols.
For the detection of the CLD protein, biotin conjugated anti-rabbit IgG was utilized as the
secondary antibody, which was then detected using streptavidin-POD. For the detection of
the DTDST protein, peroxidase conjugated anti-rabbit IgG was used as the secondary
antibody. The protein bands were visualized by chemiluminescence according to standard
protocols. For the CLD protein the pre-serum of the same rabbit was used as a negative
control. For the DTDST protein detection, normal rabbit IgG was used as a negative
control antibody.
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4. RESULTS AND DISCUSSION
4.1. Mutations in the DRA gene confirm its identity as the CLD gene (I and III)
In order to verify the role of the positional and functional candidate gene DRA in the
pathogenesis of congenital chloride diarrhea, we searched for mutations using RT-PCR
and direct sequencing on samples from CLD patients and control individuals. As an
alternative approach, genomic DNA fragments from a unipaternal disomy 7 (UPD7pat)
patient with CLD were subcloned and DRA-positive clones were selected by hybridization
with DRA cDNA fragments. The genomic fragments were sequenced, assembled, and
analyzed.
4.1.1. Mutation analysis of the DRA gene (I)
The sequencing of samples from 32 Finnish CLD patients revealed the same mutation in
all CLD chromosomes. The mutation was a homozygous in-frame three base pair deletion
(GGT) at nucleotides 951-953 that caused the loss of a highly conserved valine (V317del)
in the predicted amino acid sequence. All 43 parents studied as well as 23 of 32 healthy
sibs were heterozygous for the deletion. Three carriers were found among 252 healthy
control individuals living in Eastern Finland where the disease is more prevalent due to
founder effect. No carriers were revealed among 184 healthy controls originating from
Southwestern Finland. In addition, two unrelated Polish patients sharing an identical
haplotype in one chromosome were heterozygous for a missense A to T transversion that
resulted in the replacement of histidine by a hydrophobic leucine (H124L). Finally,
another two Polish CLD patients were found to carry a deletion of T at nucleotide position
344. The one patient was homozygous while the other was heterozygous for this single
base deletion, which created a frameshift at codon 115 and the termination of translation
18 codons downstream truncating 85% of the protein. Furthermore, a polymorphic T to G
transversion causing substitution of tryptophan for cysteine (C307W) was found 30 bp
upstream of V317del mutation at nucleotide 921 in homozygous form in all the 32 Finnish
CLD patients. We concluded that DRA causes CLD when mutated and hence be called the
CLD gene in the rest of the paper.
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4.1.2. The age of the Finnish founder mutation (I)
The reverse application of the modified Luria-Delbrück equation was utilized to estimate
the number of generations since the onset of V317del expansion in the isolated
subpopulation of Eastern Finland. The estimation was based on the actual distance
between the CLD gene and different markers around the CLD locus. The respective
generation values (g) were calculated for each marker using the following formula:
pexcess = α(1-θ)g, where pexcess= paffected-pnormal / (1- pnormal)
The value of α = proportion of mutations descending from the founding ancestor can be
set at α = 1 due to the presence of the V317del mutation in all the Finnish CLD
chromosomes. On the basis of the rough assumption that 1cM equals 1 Mb, θ can be
estimated from the high-resolution physical map. The formula is simplified by ignoring
the mutation term from the original formula (de la Chapelle, 1993).
Locus Physical distance
(Mb)
θ pexcess g
D7S658 5.3 0.053 0.22 28
D7S501 1.1 0.011 0.786 20
AFMa126zc1 0.56 0.0056 0.868 25
D7S496 0.23 0.0023 0.94 27
AFMa305ye9 0.15 0.0015 0.9677 22
AFMa297yf9 0.30 0.0030 0.907 32
D7S692 1.05 0.0105 0.734 29
D7S523 5.11 0.0511 0.446 15
D7S799 2.23 0.0223 0.693 16
The utilization of additional markers and more accurate physical distances has enabled the
adjustment of the estimation. The calculation now resulted in an average age of 24
generations, with a range of 15 to 32. This is still well in line with the population history
(de la Chapelle, 1993) and wide linkage disequilibrium interval of 13 cM across the CLD
gene region (Höglund et al., 1995). The Luria-Delbrück equation was initially designed for
the estimation of mutation rate in rapidly growing bacterial cultures (Luria and Delbrück,
1943) but has since been modified and applied successfully to the mapping of Finnish
disease genes (Lehesjoki et al., 1993; Hästbacka et al., 1992; Höglund et al., 1995). This
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was, however, the first time that the reverse application of the formula was adapted to
estimate the age of a mutation.
4.1.3. The CLD gene and protein
The CLD gene encodes a hydrophobic 764 amino acid integral membrane protein that is
variably N-glycosylated and has a predicted molecular mass of 84,5 kD (Schweinfest et
al., 1993; Byeon et al., 1996). Topology predictions suggest it to have 10, 12, or 14
transmembrane segments and a large carboxyl-terminus that is intracellular like amino-
terminus (Hästbacka et al., 1994; Silberg et al., 1995; Bairoch and Apweiler, 1996; Byeon
et al., 1996). The experimental data also support the number of transmembrane domains to
be even (Byeon et al., 1996; our unpublished results). A precise topological organization
needs to be determined experimentally, however.
4.1.4. Function of the CLD gene
After initial identification of the CLD gene as a putative tumor suppressor gene, two
different groups surveyed its function with different expression systems. Functional
studies demonstrated it to mediate a Na+-independent transport of sulfate and oxalate that
was inhibited by the anion transporter inhibitor DIDS (Silberg et al., 1995; Byeon et al.,
1996). A recent in vitro expression study using Xenopus Laevis oocytes confirmed the
role of CLD also in chloride transport and the identities of V317del as a functional
mutation and C307W as a silent polymorphism (Moseley et al., 1999). Wild type and
mutagenized CLD cRNA were injected to Xenopus oocytes and uptakes of Cl- and SO42-
were studied. Wild-type CLD-injected oocytes demonstrated transport of both anions,
while transport activity was significantly reduced in oocytes injected with the Finnish
deletion mutant V317del. Some chloride uptake was, however, detected also with this
mutant suggesting residual function retained by the defective protein. C307W, which had
been already denoted as a functionally neutral polymorphism based on genetic studies in
the Finnish population, transported both anions as efficiently as wild–type CLD. However,
in this cell model, the CLD protein demonstrated features consistent with Cl-/OH- change
and its connection with Cl-/HCO3- exchange remained somewhat unclear.
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The role of CLD in Cl-/HCO3- exchange was confirmed in vitro with HEK 293 cells stably
expressing the mouse cld gene (Melvin et al., 1999). A reversed Cl- gradient in a solution
containing HCO3- lead to a rapid intracellular alkalinization indicating the presence of Cl-
/HCO3- exchange in these cells. As expected, cld-mediated Cl-/HCO3- transport was Na+-
independent and insensitive to changes in the membrane potential. However, some
alkalinization occurred also in the absence of an extracellular HCO3- reversed Cl- gradient,
although the rate was significantly lower. The authors suggested that the extracellular
anion-binding site may be relatively nonspecific and thus alkalinization in the absence of
extracellular HCO3- may be due to the transport of other anions, such as OH- and/or
gluconate.
4.1.5. The SLC26 gene family
The CLD protein shows amino acid conservation with members of the so-called sulfate
transporter gene family, which currently consists of six well-characterized mammalian
members, and based on the EST data, many more remain unidentified (Everett and Green,
1999; Kere et al., 1999; Lohi et al., 2000). DTDST, CLD, and PDS have been identified to
be responsible for the recessive diseases if mutated, namely diastrophic dysplasia,
congenital chloride diarrhea, and Pendred syndrome, respectively (I; Hästbacka et al.,
1994; Everett et al., 1997). The functional characterization of Sat-1, DTDST, CLD, and
PDS has verified their role as anion transporters, which was already presumed on the
grounds of their homology with sulfate transporters of other species. However, they
demonstrate highly variable substrate specificities with primary anions that can readily be
implicated in the respective disease. The expanding gene family was recently renamed
solute carrier family 26 (SLC26) by Human Gene Nomenclature Committee, CLD
becoming SLC26A3 (solute carrier family 26 member 3).
SLC26A1 (also known as SAT-1) was originally isolated from a rat liver cDNA library
and encodes a high-affinity SO42-/HCO3- or SO42-/oxalate transporter (Bissig et al., 1994).
In situ hybridization study of brain tissue sections demonstrated sat-1 mRNA expression
in the hippocampus and granular cell layer of the cerebellum (Lee et al., 1999). By
western blotting and immunohistochemistry, its expression in kidney was shown to be
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restricted to the basolateral membranes of proximal tubule cells (Karniski et al., 1998).
The sequence of human SAT-1 has been recently published (Lohi et al., 2000).
SLC26A2 (alias DTDST) is discussed in more detail in the Review of the literature (see p.
24).
SLC26A4 (alias PDS) is very similar to the CLD gene at the gene level. Both genes are
located in chromosome 7q22-31.1 in tail-to-tail orientation with only ∼48 kb distance
between them, and both have very similar genomic structure (II; Everett et al., 1997).
Despite the similarities, their tissue expression pattern and substrates for transport are
different. RNA in situ hybridization study of mouse Slc26a4 has demonstrated expression
in several areas in the inner ear (Everett et al., 1999). In addition, northern hybridization
revealed an intense signal for SLC26A4 expression in thyroid (Everett et al., 1997). The
expression pattern corresponds well with the Pendred syndrome phenotype caused by the
mutations in the SLC26A4 gene. Substrate spectrum for SLC26A4 includes at least
chloride, iodide, and formate, but specifically not sulfate (Scott et al., 1999; Scott et al.,
2000).
Slc26a5 (alias prestin) was isolated from the outer hair cell cDNA pool of a gerbil as a
result in the search for the cochlear amplifier, the protein providing local mechanical
amplification in the mammalian hearing organ (Zheng et al., 2000). Its expression is
restricted to cochlear outer hair cells, and kidney cells transiently transfected with prestin
demonstrate voltage-dependent motility, which suggests the identity of prestin as the
motor protein in the cochlear outer hair cells. Substrates for its transport remain yet to be
discovered.
SLC26A6 was cloned and characterized recently as a result of an effort to expand the
SLC26 family (Lohi et al., 2000). Northern analysis suggested most abundant expression
in kidney but expression was also detected in pancreas, placenta, and skeletal muscle.
Immunohistochemistry revealed SLC26A6 protein expression in both the apical and
basolateral membranes of kidney tubule cells and in the luminal brush border of pancreatic
ducts. However, its functional role in kidney and/or pancreatic anion exchange as well as
substrates for its transport function remain to be established.
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4.2. The CLD gene consists of 21 exons and 20 introns (II)
The full coding region of the human CLD cDNA had been previously established
(GenBank number L02785; Schweinfest et al., 1993), but its genomic organization was
first determined in this study (II). Cloning and sequencing of the human CLD gene
revealed 21 exons that span approximately 39 kb of genomic DNA. The exons and introns
ranged in size from 55 to 234 bp and from 105 to 9850 bp, respectively. Initiation codon is
located in exon 2 and the termination codon in exon 21. All exon intron boundaries
confirmed with the consensus for the splice acceptors and donors. We observed one
discrepancy between nucleotide sequences obtained by the genomic sequences and the
sequence of previously published human CLD cDNA (GenBank number L02785). In the
cDNA sequence there is a 23-bp inversion and a 9-bp deletion in the beginning of exon 1.
We confirmed the genomic sequence from three independent sources of DNA and found
an identical sequence in all. This suggested a rearrangement in the published cDNA
sequence and the transcription initiation site remained uncertain. In addition, altogether 19
Alu repeats of various subclasses were identified in the introns of the CLD gene. Five of
them were truncated but 14 were typical primate repeats. (II)
In addition to CLD, our analysis of the genomic sequence obtained by large-scale
sequencing of bacterial artificial chromosome clone H_RG364P16 revealed the presence
of 10 putative exons from a separate highly homologous gene. This gene demonstrated 58
% amino acid identity to exons 9-20 of CLD and had an almost identical exon-intron
structure. During our study, this gene was shown to cause Pendred syndrome when
mutated and was named PDS (Everett et al., 1997).
The CLD gene demonstrates similar exon-intron structure as PDS with 21 exons and
SLC26A6 with 20 exons (Fig. 1). These three genes share 12 exons similar size with each
other. However, SAT-1 and DTDST have genomic structures that differ strikingly from
those of the other members (Fig. 1). SAT-1 contains three exons (Lohi H., personal
communication), whereas the DTDST gene extends over 40 kb of genomic DNA and has
two large coding exons and at least one 5’ UTR exon (Hästbacka et al., 1999).
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Figure 1. The genomic structures of the SLC26 gene family members. The exons in the
coding region are drawn in scale and darkened, while the introns and the noncoding exons
are not in scale.
A 600-bp sequence upstream from the putative transcription initiation site was analysed
using different computer programs to localize potential transcription factor binding sites.
Three potential transcription factor binding sites for AP-1 were found as well as three
motifs for the erythroid specific transcription factor GATA-1. There were two potential
CCAAT boxes and a putative TATA box located at an optimal position at nt –33 upstream
of the putative transcription start site. (II)
This study enabled us to design primer pairs for amplifying each exon separately. All exon
specific PCR reactions work well in the same conditions and can thus be performed
simultaneously.
4.3. Mutation spectrum of the CLD gene (I, III)
The identification of the CLD gene, the determination of its genomic organization, and
the design of exon specific intronic primers enabled an extensive screening of mutations in
the patients with CLD originating from several different populations. The amplified
samples were first screened by the SSCP analysis and fragments suggesting a mobility
shift were further analyzed by sequencing to characterize sequence variations. Some
samples showing no mobility shift in the SSCP screening, originating from populations
with founder mutations, or the mutation hot-spot regions were sequenced directly after
PCR amplification. Finally, to rule out the possibility of polymorphism, the presence of
the sequence variation was studied in a set of control individuals.
CLD
PDS
SLC26A6
PRESTIN ?-- --?
SAT-1
DTDST
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Analysis of the coding region and exon-intron boundaries of the CLD gene in CLD
patients has revealed a wide spectrum of different sequence alterations. Regardless of
ethnic background, in all cases mutations have been detected in the CLD gene suggesting
no locus heterogeneity in CLD. To date, 28 different mutations have been identified
among c. 100 CLD patients, most of whom originate from the three high-frequency
populations (Table 1; I, III, Etani et al., 1998; Höglund et al., 1998; Höglund et al.,
submitted). Approximately 34% of the mutations are single base pair substitutions, 38%
small insertions or deletions, and 17% splice-site defects. The first two genomic
rearrangements have been characterized recently (Höglund et al., submitted). In addition,
four polymorphisms have been detected. So far, no whole gene deletions, promoter region
mutations, or de novo mutations have been reported. Mutations are distributed throughout
the coding sequence of the CLD gene, although some clustering can be seen, suggesting
either the functional importance or mutation-prone structures of these regions (Fig. 2). The
cluster nearest to the 5’ end (nucleotides 344-392) is located in a region called “sulfate
transport domain” with a strong amino acid conservation between family members even
across species. Four different mutations (344delT, H124L, G120S, and P131R) lie in this
cluster consisting of only 49 bp. A wider putative cluster contains 40% (12/28) of the
mutations detected so far within a 326 bp area (nucleotides 1306-1631) that comprises
14% of the CLD protein.
Figure 2. The genomic structure of the human CLD gene showing the distribution of the
28 mutations characterized so far. Circles indicate the point mutations, triangles deletions,
inverted triangles insertions, and diamonds splice site mutations. The square indicates the
replacement mutation. Open symbols indicate missense mutations, while nonsense
mutations are indicated with solid symbols. Gray symbols indicate polymorphisms.
1 2 3 4 5 6 7 8 9 10 11 12 14 15 16 17 18 19 20 2113
Table 1. Mutations of the human CLD gene
4.3.1. Founder mutations
Although rare cases of CLD occur worldwide, the clustering of CLD cases in the
certain high incidence areas suggests a founder effect and thus the presence of a single
major founder mutation in each of these populations. In Finland, V317del mutation has
been found in all but one disease associated chromosomes, accounting for 98% of
mutations. This finding is in agreement with earlier haplotype data suggesting one
major mutation to be responsible for the disease in Finnish population (Höglund et al.,
1995). This also coincides with the population history and geographic isolation of
Finland, which have lead to the enrichment of certain alleles and depletion of others in
the Finnish population (Norio et al., 1973; de la Chapelle, 1993). Finnish V317del
mutation and the C307W polymorphism were detected also in seven out of eight
Swedish CLD-associated chromosomes, as was expected on the basis of haplotype
Mutation Intron/Exon Nucleotide change Result References
177-178insC exon 3 insertion of C at 177-178 frameshift, truncated III
268-269insAA exon 3 insertion of AA at 268-269 frameshift, truncated Höglund et al. 1998
344delT exon 4 deletion of T at 344 frameshift at codon 155, truncated I
G120S exon 4 G to A at 358 glycine to serine at codon 120 III
H124L exon 4 A to T at 371 histidine to leucune at codon 124 I
P131R exon 5 C to G at 392 proline to arginine at codon 131 III
G187X exon 5 G to T at 559 glycine to stop at 187, truncated Höglund et al. 1998
IVS5-2A>G intron 5 A to G at 571-2 destruction of the intron acceptor AG Höglund et al. 1998
IVS5-1G>T intron 5 G to T at 571-1 destruction of the intron acceptor AG Höglund et al. 1998
S206P exon 6 T to C at 616 serine to proline at codon 206 Höglund et al. submitted
exon 7-8 deletion intron 6-intron 8 3.5 kb deletion of genomic DNA loss of exons 7 and 8, frameshift Höglund et al. submitted
Y305X exon 8 C to A at 915 tyrosine to stop at 305, truncated III
V317del exon 8 deletion of GGT at 951-953 in-frame loss of a valine at 317 I
Q436X exon 11 C to T at 1306 glutamine to stop at 436, truncated Höglund et al. submitted
IVS11-1G>A intron 11 G to A at 1312-1 destruction of the intron acceptor AG Höglund et al. 1998
1342-1343delTT exon 12 deletion of TT at 1342-1343 frameshift, truncated Etani at al. 1998
D468V exon 12 A to T at 1403 aspartic acid to valine at codon 468 Höglund et al. submitted
IVS12-1G>C intron 12 G to C at 1408-1 destruction of the intron acceptor AG Höglund et al. submitted
L496R exon 13 T to G at 1487 leucine to arginine at codon 496 Höglund et al. 1998
IVS13-2delA intron 13 deletion of A at 1515-2 destruction of the intron acceptor AG Höglund et al. submitted
1516delC exon 14 deletion of C at 1516 frameshift, truncated III
1548-1551delAACC exon 14 deletion of AACC at 1548-1551 frameshift, truncated III
Y527del exon 14 deletion of TTA at 1578-1580 in-frame loss of a tyrosine at 527 III
1609delA exon 15 deletion of A at 1609 frameshift, truncated Höglund et al. 1998
I544N exon 15 T to A at 1631 isoleucine to asparagine at codon 544 Höglund et al. submitted
I675-676ins exon 18 insertion of ATC at 2025-2026 in-frame addition of an isoleucine Höglund et al. 1998
2104-2105delGGins29 exon 19 replacement of GG with 29 bp frameshift, truncated Höglund et al. submitted
2116delA exon 19 deletion of A at 2116 frameshift, truncated III
Polymorphism
C307W exon 8 T to G at 921 cysteine to tryptophan at 307, function I
1299G/A exon 11 G to A at 1299 no change at amino acid level Höglund et al. submitted
1314C/T exon 12 C to T at 1314 no change at amino acid level Höglund et al. submitted
R554Q exon 15 G to A at 1661 arginine to glutamine at 544 Höglund et al. submitted
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analysis (Höglund et al., 1995). This is in agreement with recent emigration from
Finland to Sweden. Distinctive founder mutations have also been recognized in Saudi
Arabia and Kuwait as well as in Poland (Höglund et al., 1998). In Saudi Arabia and
Kuwait the high incidence of CLD most likely owes the combination of a founder
effect with a high frequency of consanguinity. A nonsense point mutation G187X has
been demonstrated in 94% (17 /18) of disease chromosomes (Höglund et al., 1998). In
Poland the situation is somewhat more complicated. There the major insertion mutation
was found only in 47% of CLD-associated chromosomes, which together with more
rare mutations results in compound heterozygotes and thus the higher disease frequency
(Höglund et al., 1998).
4.3.2. Small deletion and insertion mutations
Seven small deletions or insertions were found during this study and four more have
been reported later (Höglund et al., 1998; Höglund et al., submitted). Of these, eight
result in a frameshift and lead to the premature termination of protein translation and
three are in-frame changes. The Finnish founder mutation at codon 317 causes in-frame
loss of a valine which is highly conserved within human SLC26 family members (I). Its
pathogenicity has recently been verified (Moseley et al. 1999). Another in-frame
mutation is the loss of a tyrosine at codon 527 removing a highly conserved amino acid
(III). The Polish founder mutation, an in-frame addition of an isoleucine at codon 676,
is located at the long intracellular carboxyterminal tail (Höglund et al., 1998). The most
proximal mutation is an insertion of a C between the nucleotides 177 and 178, leading
to a nonsense change at codon 60 and stop at codon 70 (III). The most distal mutation
is a deletion of a single A causing frameshift and nonsense change at codon 706 and
stop at codon 711, found in heterozygous form in one Finnish patient (III). The most
distal mutation leaves more than 90% of the protein intact truncating only the very end
of the intracellular C-terminal end. In addition, four other frameshift mutations truncate
one-third or less of the protein. Based on the phenotype, no remarkable residual activity
is however retained, which suggests the C-terminal region to be of great importance for
the proper function of the CLD protein.
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4.3.3. Point mutations
In this study, we found three missense mutations and one nonsense point mutation.
Three more missense and two nonsense mutations have been reported later (Höglund et
al., 1998; Höglund et al., submitted). Most single nucleotide substitutions hit
evolutionary conserved amino acid residues which can thus be expected to affect the
functional domains of the protein. The only “non-Finnish” Swedish disease
chromosome carried a G to A transition leading to a glycine to serine change at codon
120, which was also found in a Polish and a Norwegian patient (III; Höglund et al.,
submitted). Different haplotypes suggest that the mutation has occurred three times.
The substituted glycine is highly conserved and invariant in all six SLC26 family
members, as is also the next histidine at codon 124 that is changed to leucine due to an
A to T missense mutation (I). However, proline at codon 131 that is changed to
arginine by a C to G transversion (III) is found only in pendrin in addition to the CLD
protein. All these three missense mutations reside in the most homologous area called
the sulfate transport domain. Also a leucine to arginine change at codon 496 (Höglund
et al., 1998) affects a conserved amino acid identical in five of the mammalian SLC26
family members.
After this study the first large genomic rearrangements have also been found (Höglund
et al., submitted).
4.3.4. Polymorphisms
So far only four polymorphic sequence variations have been detected in the CLD gene.
Two of the polymorphisms are silent single nucleotide substitutions, while two are
polymorphic both at the gene and the protein level. Both the C307W and R554Q
polymorphism change unconserved amino acids. The C307W change was originally
found to occur in homozygous form in association with V317del mutation in Finnish
CLD patients (I). However, also two healthy individuals demonstrated it in
homozygous form and the carriership was detected to be more than ten-fold of that
predicted for CLD. The C307W polymorphism has later been detected in different
populations suggesting it to be a common polymorphism outside Finland as well.
Functional testing has verified its neutral nature (Moseley et al., 1999). It is possible
53
that some of the missense single nucleotide changes turn out to be rare silent
polymorphisms in functional testing.
4.4. CLD has a limited expression pattern and DTDST partially colocalizes with it
4.4.1. Northern analysis (I)
A multiple tissue northern blot (Clontech) was hybridized with a CLD cDNA probe in
order to obtain a general overview of the expression pattern of the human CLD gene.
The northern analysis suggested a restricted expression pattern for CLD, demonstrating
a single 3.7-kb transcript with a strong signal in colon and prostate (I). A weak signal
was observed in small intestine and an extremely weak one in testis. No signal was
detected with spleen, thymus, ovary, and peripheral blood leukocyte mRNA.
4.4.2. In situ hybridization and immunohistochemistry (I, IV, V, unpublished
data)
We performed in situ hybridization and immunohistochemistry in order to establish the
expression pattern of the human CLD gene and protein, which aids in defining the
normal physiological role of this anion transporter and also elucidates the mechanisms
underlying congenital chloride diarrhea. CLD expression was studied in vivo in various
normal human epithelia and in inflammatory and neoplastic colonic epithelia. Intestinal
samples of a CLD patient were also included.
Northern blot analysis suggests the homologous anion exchanger DTDST to have an
ubiquitous tissue distribution including intestine, although cartilage is the only tissue
known to be affected by its defective function (Hästbacka et al., 1994; Satoh et al.,
1998). The expression pattern of the human DTDST gene was also studied and
compared with that of CLD in order to reveal the possible colocalization of these
homologous anion transporters.
As expected, strong expression for both the CLD mRNA and protein was detected in
ileal and colonic surface epithelium. The intestinal samples of the patient with CLD
and the inflammatory colon samples demonstrated CLD expression similar to the
normal control. In the neoplastic colonic epithelium, the expression of CLD appeared
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to depend on the differentiation level: the poorer the differentiation, the lower the CLD
expression. DTDST partially colocalized with CLD in colon. Of the other epithelial
tissues studied, only eccrine sweat gland showed both CLD and DTDST expression. In
addition, CLD was expressed in seminal vesicle, while the expression of DTDST could
be detected in fetal and mature cartilage, placenta, bronchial glands, tracheal
epithelium, and pancreas. (I, IV, V)
Histologically normal colon (I, IV)
In situ hybridization of normal colonic sections revealed a strong signal for CLD
mRNA in the luminal surface epithelium and the upper one-third of the colonic crypt
(I). The signal was less intense or absent in the base areas of the crypts. The
immunostaining for the CLD protein colocalized with mRNA signal in the colon
epithelium (IV). An intense CLD expression was detected both in the apical side of the
nucleus in the cytoplasm and focally in the brush border of the absorptive epithelial
cells.
The expression of the CLD protein in the brush borders of luminal enterocytes is
consistent both with its identity as a membrane glycoprotein (Byeon et al., 1996) and
with its suggested function in chloride absorption. The absorptive processes in colon
are known primarily to be located at the luminal surface epithelia where substances to
be absorbed are in a close contact with the epithelia. In addition, strong
immunostaining for the CLD protein was detected in the cytoplasm in the apical side of
nucleus, which most likely indicates a high level of synthesis and presence of the
nascent CLD protein in enterocytes.
Intestinal samples of the CLD patient (I, unpublished data)
Normal or close to normal expression of CLD mRNA was detected in a colon sample
from a Finnish CLD patient with V317del mutation (I). In the appendix of a CLD
patient, the immunostaining of the CLD protein was found to be similar to a normal
control (Fig. 3; unpublished data). However, these methods do not permit the
quantitative evaluation of CLD mRNA and protein levels. Despite normal protein
production, a mutation can affect its targeting, stability and function which is clearly
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defective in the patients with CLD. The abolished function resulting from the Finnish
founder mutation V317del has recently been established (Moseley et al., 1999).
Figure 3. Expression of the human CLD protein in the appendix of a CLD patient.
Anti-CLD serum demonstrates immunoreactivity in the apical side of the nucleus in the
surface epithelial cells (A). In contrast, a serial section stained with preimmune serum
shows no specific immunoreactivity (B).
Inflammatory bowel samples (IV)
Impaired Cl- absorption in exchange for bicarbonate suggesting defective function of an
active Cl-/HCO3-exchange mechanism is detected in ulcerative colitis (Caprilli et al.,
1986). However, no significant change in CLD mRNA and protein expression was
detected in the samples with ulcerative, Crohn’s, and ischemic colitis (IV), although
both inflammation and IL-1 stimulation have previously been reported to reduce the
expression of the CLD gene (Yang et al., 1998). Normal cytoplasmic immunostaining
for the CLD protein was detected even in the samples with active inflammation or
epithelium bordering ulcerations (IV). While brush border staining was missing in
ulcerative colitis, the brush border in the samples with Crohn’s or ischemic colitis
demonstrated immunoreactivity similar to the normal control (IV). A chronically
inflamed rabbit ileum has demonstrated inhibition in villus Cl-/HCO3- exchange, which
is a secondary phenomenon due to a decrease in the affinity for Cl- without an
alteration in transporter numbers (Coon and Sundaram, 2000). The specific transport
protein was not, however, established.
Some evidence also suggest that different inflammatory mediators may specifically
regulate different transport pathways in a chronically inflamed tissue (Sundaram et al.,
A B
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1997; 1998a; 1998b). The role of cytokines in the mucosal immune system has been
studied intensively and an altered expression profile of colonic mucosal chemokines
was reported in inflammatory intestinal tissues. In IBD, a disturbed balance between
proinflammatory and anti-inflammatory cytokines has been suggested to play an
important role in the maintaining of chronic inflammation (Casini-Raggi et al. 1995;
Noguchi et al. 1998). Cytokines have also been shown to alter epithelial ion transport
and permeability (McKay and Baird 1999). Despite extensive studies on inflammatory
cytokines, little is known about the regulation of enterocytic protein expression by
inflammatory cytokines. However, when surface epithelium was absent or severely
affected, the expression of the CLD protein was found to be redistributed to the lower,
more dedifferentiated, parts of the. Even the base areas near the muscularis mucosae
showed positive immunostaining in some samples crypts (unpublished data). This is the
first evidence of the up-regulation of CLD. Local factors associated with tissue vitality
may act as regulators of the expression of CLD.
Increased proliferative activity in IBD has previously been shown in terms of
expansion of the proliferative zone of the colonic crypt up to the lower two-thirds of the
crypt (Serafini et al., 1981). We show that CLD is expressed also in the proliferative
zone (IV), suggesting that the expression of CLD is not limited to non-proliferating
cells, although in normal tissues no CLD expression is usually observed in the cells of
the proliferative cell compartment.
Proliferative epithelial lesions of the colon (IV)
We studied the expression of CLD in a set of different colonic tumors, including all
stages of colon tumor progression, in order to clarify the role of its down-regulation in
the neoplastic transformation and progression. In these tumors, we found a variable
CLD expression pattern that was dependent on the differentiation status. Adenomatous
polyps with mild to moderate dysplasia demonstrated cytoplasmic immunostaining that
was reduced but clearly present in all samples (IV). However, the brush border
immunoreactivity normally found in the apical membrane could not be detected. In
more advanced dysplasias and adenocarcinomas also the cytoplasmic staining was
gradually lost, although the non-neoplastic epithelium adjacent to tumors expressed
CLD normally (IV).
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Initially, the CLD gene was isolated as a putative tumor suppressor gene on the basis of
its down-regulated expression in colon adenomas and adenocarcinomas (Schweinfest et
al., 1993). Further studies demonstrated some correlation between down-regulation and
tumor progression, and down-regulation was suggested to be particularly significant in
the earliest phases of the neoplastic evolution (Antalis et al., 1998). An epidemiological
survey on the incidence of cancer among CLD patients with a non-functional V317del
germline mutation and their parents (obligatory carriers) gave little clinical support to
this hypothesis. The total cancer incidence was unchanged, although a slightly elevated
risk of colon cancer was found (Hemminki et al., 1998). Since the patients homozygous
for this mutation thrive well without prominent cancer predisposition, a major role of
CLD in the initiation of cancer is unlikely. However, all CLD patients studied were
young (all under 32) owing to the lethality of CLD in the past and further follow-up
would thus be beneficial for the accurate determination of their cancer risk.
Furthermore, in the expression analysis, normal or close to normal expression was
revealed in the intestinal samples of a Finnish patient homozygous for V317del
mutation. Thus, the localization of the CLD protein can be defective causing the
dysfunction of the anion transport properties, but the protein is translated and may have
retained the ability to interact with other proteins in addition to its putative function as
tumor suppressor. Finally, although a recent in vitro study has demonstrated functional
defect of V317del mutation, some retained activity could be detected (Moseley et al.,
1999).
Our results indicate that CLD is intensely expressed in the normal and benign colon
surface epithelium and that its down-regulation is a common but later event in the
neoplastic evolution of colonic mucosa than previously thought. The significance of
this finding remains open; the putative tumour-suppressor capability of CLD appears
unlikely, however. These findings demonstrate that the expression of CLD is limited to
a highly mature epithelium and loss of expression reflects loss of terminal
differentiation.
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DTDST is partially colocalized with CLD in a normal human colon (IV, V)
The colon surface epithelium demonstrated both DTDST mRNA and protein
expression. A strong signal for the DTDST mRNA was detected in the upper one-third
of the colonic crypt epithelium, while the signal was absent both in the luminal surface
epithelium and the base areas of the crypts (IV). Immunohistochemistry confirmed a
similar protein expression pattern (V). Interestingly, there was some variability in
immunostaining depending on the pre-treatment used. When epitopes were unmasked
with a gentle SDS incubation, the surface epithelial cells and especially apical cell
membranes demonstrated strong immunoreactivity. In contrast, when epitopes were
unmasked using the microwave treatment, the immunostaining was detected in the
cytoplasm at the apical side of the nucleus corresponding to the area of Golgi
apparatus. The heavy microwave treatment most likely unmasks epitopes hidden deeper
in the cell, probably corresponding with the protein under construction and processing
in Golgi apparatus, but simultaneously it destroys the apical, most likely functional,
form of the protein.
Interestingly, in the colon DTDST is localized between two known chloride
transporters, namely CFTR, which secretes chloride and is located in the bottom areas
of the crypt (Strong et al., 1994), and CLD, which absorbs chloride in the exchange for
bicarbonate and is localized in the upper one-third of the crypt and the lumenal surface
epithelium (I; IV). Although DTDST partially colocalizes with CLD, it is clearly
unable to compensate for the defective function of CLD as is shown by the strong
diarrheal phenotype in congenital chloride diarrhea. However, the possible role of
DTDST between two important transporters as a regulator or modifier remains yet to be
solved. Chloride secretion into the crypts, mainly mediated by CFTR, has been
suggested to regulate bicarbonate secretion of luminal enterocytes. The location of
DTDST in the upper-one third of the crypt provides it with excellent possibilities to
modify luminal chloride content. It is already known that CFTR induces the expression
of CLD when expressed simultaneously in tracheal epithelial cells (Wheat et al., 2000).
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The colon is a site of major macromolecular sulfation due to the large number of cells
producing protective mucus. Colonic mucus is composed of protein and
oligosaccharides that are heavily sulfated in contrast to mucin from other parts of the
gastrointestinal tract (Goso and Hotta, 1993). Sulfate anion concentrations in colonic
lumen vary conciderably in different diets (Florin et al., 1991), but many species of
bacteria in the colon are able to degrade the highly sulfated macromolecules, releasing
free sulfate which would then become available for uptake to epithelial cells. In
addition, in vivo studies have indicated sulfate absorption from the gut (Krijgsheld et
al., 1979). As a sulfate transporter with colonic expression, SLC26A2 might well have
a role in an inorganic sulfate uptake for the abundant synthesis of highly sulfated
macromolecules in colon epithelial cells.
Eccrine sweat glands demonstrate both CLD and DTDST expression (IV, V)
The luminal side and intercellular canaliculi of the epithelial cells in the coiled
secretory part of eccrine sweat gland demonstrated abundant immunoreactivity for the
CLD protein (IV). Also both DTDST protein and mRNA expression were detected in
the same structures (V). The main electrolytes of primary sweat are sodium, chloride,
potassium, and bicarbonate (Bijman, 1987). Sweat also contains some proteins. The
presence of proteolytic enzymes as well as mucin has been established (Seutter et al.,
1970). It is, however, controversial if these sulfated macromolecules are true
derivatives of sweat rather than contaminants from the skin surface. The mechanisms
responsible for primary sweat formation are not clear but a complex co-ordination of
multiple ion transporters has been suggested (Bijman, 1987). At least during
cholinergic sweat secretion Cl-/HCO3- and Na+/H+ exchangers have been suggested to
participate in the control of sweat composition, although the main role has been
assigned to Na+-K+-2Cl- cotransporters (Sato et al. 1989). The localization of
transporters like CLD and DTDST to the secretory part of eccrine sweat glands is not
surprising, since a need for especially chloride, but also sulfate transport, has been
established. More studies are needed to reveal their possible involvement in the primary
sweat formation.
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CLD is expressed in seminal vesicle (IV)
In addition to colon, northern analysis suggested strong expression of CLD mRNA in
the prostate. At the histological level, however, both the stromal and epithelial tissues
of the prostate itself remained negative for CLD mRNA and protein but expression was
found in intra- and extraprostatic seminal vesicles (IV). Microvilli of the secretory
columnar cells of ductal epithelium, in particular, demonstrated strong
immunoreactivity. The seminal vesicle fluid contains a high concentration of HCO3-
(Okamura et al., 1985) and CLD might well be involved in this process, since its
intestinal manifestation includes a defect in Cl-/HCO3- exchange (Holmberg et al.,
1975). At ejaculation, the alkalic seminal vesicle fluid mixes with stored sperm
activating the motility of the primarily quiescent sperm. Defects in the neutralization
process result in acidity of the luminal fluid, causing hypomotility of the sperm and
infertility/subfertility (Breton et al. 1996). It is important to re-evaluate the clinical
significance of the seminal vesicular expression of the CLD gene in male CLD patients.
DTDST is expressed in fetal and mature cartilage (V)
In in situ hybridization, developing diaphysic cartilage of fetal limb long bone at
gestational week 12 demonstrated strong signal for DTDST mRNA (V). The only adult
cartilage showing DTDST mRNA expression was bronchial cartilage (V). Although
both DTDST protein and mRNA levels in adult cartilage were almost undetectable, a
strong signal for DTDST mRNA was observed in developing fetal cartilage. The
proteoglycan composition of human cartilage does not remain constant throughout life.
In the fetal period, chondroitin sulfate predominates and structural changes of cartilage
proteoglycans are small. There is, however, considerable variation in both the degree
and position of sulfation of chondroitin sulfate (Roughley et al., 1987). In in situ
hybridization, the fetal DTDST expression was detectable in most mature hypertrophic
chondrocytes in diaphysis of developing bone at gestational week 12. At the same time
6-sulfation, which is more sensitive to extracellular inorganic sulfate depletion (Ito et
al., 1982; Rossi et al., 1996), predominates in chondoitin sulfate chains (Roughley et
al., 1987). Concurrently vasculature is only starting to penetrate developing bone. 6-
sulfation has also been demonstrated to be more essential for the growth response of
the cells to fibroblast growth factor (Pye et al., 1998), which has already been shown to
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be dependent on overall sulfation of matrix proteoglycans (Satoh et al., 1998).
Therefore, although chondrocytes, together with other cells, are to some extent able to
utilize alternative sulfate sources in proteoglycan biosynthesis, the availability of
sulfated aminoacids is not adequate to meet the enhanced demand in a practically
avascular tissue like cartilage.
DTDST is expressed also in other epithelial tissues (V)
Placental syncytiotrophoblasts function as an absorptive epithelium providing essential
nutrients, including sulfate, for the fetus. The syncytiotrophoblast apical surface as well
as some cytoplasmic granules have been reported to contain at least chondroitin sulfate,
a highly sulfated glycoconjugate (Parmley et al., 1984). In addition, the presence of an
active, Na+-independent, and an anion transport inhibitor (DIDS) sensitive sulfate
transport mechanism in human placental tissue has been reported (Cole and Rastogi,
1991). The localization of DTDST in human placental sycytiotrophoblasts makes it an
excellent candidate for participating in maternofetal sulfate transport in addition to
providing inorganic sulfate for macromolecule biosynthesis.
Histologically, submucosal seromucous bronchial glands and tracheal epithelium
demonstrated strong DTDST mRNA and protein expression. In bronchial sections,
DTDST was abundant in cells of airway submucosal glands and in tracheal epithelium.
Airway mucus is primarily produced in mucus-producing cells of submucosal glands
and is known to be extremely highly sulfated. The presence of a SO42-/Cl- exchanger in
apical membrane of tracheal epithelial cells has been proposed (Elgavish et al., 1987).
35S-sulfate incorporation studies have shown an uptake into secretory cells both in the
tracheal epithelium and submucosal glands (Svitacheva et al., 1998). The localization
of DTDST in submucosal glands as well as tracheal epithelium suggests that it is an
excellent candidate to be responsible for sulfate uptake in these structures.
Chloride secretion has been postulated to regulate HCO3- secretion by pancreatic duct
cells. CFTR is responsible for most chloride transport, but other Cl--channels
participate (Nguyen et al., 1997). There is also evidence for a SO42-/Cl- exchange
mechanism (Elgavish and Meezan, 1992). In addition, a protective layer of sulfated
mucin covers pancreatic ducts. It is also interesting to observe that material in the
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acinar lumen stained strongly with anti-DTDST serum. This might well indicate that
the DTDST protein is ultimately degraded and extruded from the cell cytoplasm to
acinar lumen.
In bronchi, sweat glands, and pancreas, DTDST colocalizes with the chloride secretor
CFTR (Trezise and Buchwald, 1991; Engelhardt et al., 1992; Sato and Sato, 2000).
Interestingly, mucus of cystic fibrosis patients is reported to contain oversulfated
glycoconjugates at least in the respiratory tract and in the intestine (Zhang et al., 1995;
Hill et al., 1997). Mutations in the CFTR gene cause defective chloride secretion.
DTDST has an ability to secrete chloride in exchange for sulfate and might be trying to
compensate for the chloride transport defect of CFTR, thus resulting in the transport of
extra sulfate into the cells in exchange for chloride. Abundant sulfate might then be
conjugated to sulfated proteoglycans in order to excrete it and to maintain intracellular
electrolyte balance.
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CONCLUSIONS AND FUTURE PROSPECTS
In this study the gene for congenital chloride diarrhea (CLD) was identified and its
genomic structure was determined, making extensive mutation screening possible. The
in vivo expression of CLD and highly homologous diastrophic dysplasia sulfate
transporter (DTDST) was studied in different tissues and cell types and the expression
of DTDST was compared to that of CLD.
Summarizing the results, strong evidence suggests CLD to be the major Cl-/HCO3-
transporter responsible for the electronegative Na+ coupled Cl- absorption in ileal and
colonic epithelial cells. First, intestinal perfusion studies in CLD patients demonstrate
defect in apical Cl-/HCO3- exchange in distal ileum and colon (Holmberg et al., 1975).
Second, the DRA gene causes CLD, if mutated (I; III). Third, CLD is located in the
brush border of colonic surface epithelial cells (I, IV; Byeon et al., 1996). Fourth, in
vitro functional data show CLD-mediated Cl-/HCO3- exchange activity (Melvin et al.,
1999; Moseley et al., 1999).
The presence of a major founder mutation in Finland and the Arabic countries covering
over 98% and 94% of disease chromosomes, respectively, facilitates the diagnostic
possibilities of CLD in these high-frequency areas. It is now possible to offer fast and
reliable pre- and postnatal diagnostics as DNA-based testing is available. Also carrier
testing is facilitated and genetic counseling will be improved. Early diagnosis allows
the people involved, both family members and health care personnel, to be prepared for
possible prematurity. At present, treatment involves the replacement of continuous
fluid and electrolyte losses. Appropriate treatment from birth will have positive
influence on the patients’ entire life; correctly treated patients are likely to develop
normally and survive without kidney failure.
The mutations identified in the CLD gene show a wide spectrum of DNA variations
including missense and nonsense point mutations, splice-site mutations, as well as
insertions and deletions. They are distributed throughout the CLD protein, although
some clustering can be observed. Studies using mutagenized constructs will clarify the
effect of different mutations on the structure and function of the CLD protein. The
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protein structure, however, remains to be experimentally determined in order to reveal
the protein domains affected by the mutations.
Multiple truncating mutations are located in the long C-terminal most likely
intracellular tail of the CLD protein. On the basis of the CLD phenotype, even most C-
terminal mutations abolish the transport function, which suggests these areas to be of
great importance for the proper function of the CLD protein. Some intestinal transport
proteins, such as cystic fibrosis conductance regulator (CFTR) and sodium-hydrogen
exchanger 3 (NHE3), are regulated by distinct domains in the C-terminal end of the
protein. The presence of specific regulatory domains and their potential role for
functional regulation of the CLD protein need to be verified.
During this study, a growing family of anion transporters with members across a large
taxonomic span was recognized. To date, the gene family consists of six well-
characterized mammalian members, while further studies are likely to reveal new ones
(Lohi et al., 2000). Interestingly, besides CLD, two other genes associated with the
distinct genetic diseases, namely PDS and DTDST, reside within the same gene family.
All the family members are structurally well conserved but still play central roles in
very distinct physiological functions including gut absorption, cartilage growth, and
hearing. This mostly results from different tissue expression profiles in addition to
distinct substrate specificity. The expansion of the family with the novel members and
their functional characterization is likely to provide important knowledge on anion
transport physiology in different parts of the human body.
Immunohistochemistry demonstrated strong CLD expression at the brush-border of
ileal and colonic epithelial cells, but also cytoplasmic immunostaining on the apical
side of the nucleus was detected. The development of CLD-specific antibodies
enhances the studies of the intracellular processing, transport, and localization of CLD
in the mammalian cell. The expression of the homologous anion transporter DTDST
was partially overlapping with the CLD expression. Based on the CLD phenotype, it is
obvious that DTDST is not able to compensate for the defective function of CLD.
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Intestinal electroneutral NaCl absorption and thus also the mechanisms responsible for
it are tightly regulated and it is most likely that different mechanisms are involved at
different stages of the digestive process. Further in vivo and in vitro studies are needed
to reveal the relative contribution of CLD to the basal and stimulated Cl- absorption in
ileum and colon. Its role in other physiological functions like intracellular pH and cell
volume regulation is also subject to further investigation.
Although a lot of information has accumulated on the human CLD gene, we are just
beginning to understand the molecular background of congenital chloride diarrhea. It is
obvious that much work has to be done to define the cellular and molecular
mechanisms underlying the function of the CLD protein. Its exact biochemical and
physiological role and its association with ileal and colonic Cl-/HCO3- exchange are not
fully understood. Many basic properties affecting its function, such as the cell-specific
regulation, the molecular mechanism of coupling, and the way the transport is
energized, are subjects for further study. We understand neither how its substrate
selectivity is determined nor how the ions are moved across the membrane. The
investigation of the biosynthesis, trafficking, and degradation of the CLD protein would
provide knowledge of the transporter at cellular level.
Identification of the CLD gene will, thus, start a new era in studies on an intestinal
anion transport physiology and on the molecular pathophysiology of congenital
chloride diarrhea.
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